Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2019 / Article

Review Article | Open Access

Volume 2019 |Article ID 2909632 | 37 pages | https://doi.org/10.1155/2019/2909632

Signal Transduction Pathways of Acupuncture for Treating Some Nervous System Diseases

Academic Editor: Min Li
Received25 Apr 2019
Accepted23 Jun 2019
Published11 Jul 2019

Abstract

In this article, we review signal transduction pathways through which acupuncture treats nervous system diseases. We electronically searched the databases, including PubMed, MEDLINE, clinical Key, the Cochrane Library, and the China National Knowledge Infrastructure from their inception to December 2018 using the following MeSH headings and keywords alone or in varied combination: acupuncture, molecular, signal transduction, genetic, cerebral ischemic injury, cerebral hemorrhagic injury, stroke, epilepsy, seizure, depression, Alzheimer’s disease, dementia, vascular dementia, and Parkinson’s disease. Acupuncture treats nervous system diseases by increasing the brain-derived neurotrophic factor level and involves multiple signal pathways, including p38 MAPKs, Raf/MAPK/ERK 1/2, TLR4/ERK, PI3K/AKT, AC/cAMP/PKA, ASK1-JNK/p38, and downstream CREB, JNK, m-TOR, NF-κB, and Bcl-2/Bax balance. Acupuncture affects synaptic plasticity, causes an increase in neurotrophic factors, and results in neuroprotection, cell proliferation, antiapoptosis, antioxidant activity, anti-inflammation, and maintenance of the blood-brain barrier.

1. Introduction

Acupuncture is a form of therapy practiced for more than 3000 years in Asia. Medical doctors practice acupuncture under the guidance of meridian theory to achieve “de qi” status [1]. To perform acupuncture, doctors use thin and sterile metal needles to penetrate specific stimulation points termed acupoints. Both manual and electroacupuncture (EA) are used in medical practice. Many studies have reported the benefits of acupuncture for treating diseases such as stroke, musculoskeletal disorders, chronic urticaria, irritable bowel syndrome, overactive bladder, cancer-related fatigue, and pain in humans [26]. Furthermore, few adverse effects have been observed when acupuncture is performed correctly, even in children and pregnant women [7, 8]. The widely known mechanism of acupuncture is that it results in the secretion of endorphins that exert an analgesic effect. With advances in understanding, more mechanisms of acupuncture have been determined, including the local segmental effect, somatoautonomic reflex, immune system regulation, neurotransmitter modulation, the neuroendocrine effect, and the functional connectivity neural network [911].

Nowadays, signal transduction has been applied for explaining acupuncture mechanisms. The signal transduction pathway of acupuncture has been mentioned with respect to many diseases, including neurological [12], cardiovascular [13], metabolic [14], and gynecological [15] diseases. Among the aforementioned diseases, nervous system diseases are the most common complaints in daily practice. When used to treat nervous system diseases, acupuncture enhances cell proliferation and neuroblast differentiation by increasing the levels of brain-derived neurotrophic factor (BDNF) and phosphorylated cyclic AMP response element-binding (CREB) protein [16]. Acupuncture was reported to exert a neuroprotective effect on dopaminergic neurons through anti-inflammatory and neurotrophic effects [17]. Other mechanisms, including antioxidation, antiapoptosis, and improved energy metabolism in the brain, have been reported [1820]. Although many studies on the signal transduction pathway of acupuncture have been conducted, few reviews have been published on this topic. In the present review, we discuss the involvement of the signal transduction pathway as a mechanism underlying the effects of acupuncture when used for treating nervous system diseases.

2. Method

We electronically searched the databases, including PubMed, MEDLINE, clinical Key, the Cochrane Library, and the China National Knowledge Infrastructure from their inception to December 2018 using the following MeSH headings and keywords alone or in varied combination: acupuncture, molecular, signal transduction, genetic, cerebral ischemic injury, cerebral hemorrhagic injury, stroke, epilepsy, seizure, depression, Alzheimer's disease (AD), dementia, vascular dementia (VD), and Parkinson’s disease (PD). In addition, we used Boolean operators (“not,” “and,” ”or”) to narrow or widen search results. All articles written in English or Chinese were manually screened, and relevant studies were identified. We included additional articles after performing a manual review of the reference lists of identified studies or review articles. Excluded articles included those with unavailable full text, those written in other languages, those not mainly related to the mechanism of the signal transduction pathway, or those with limited details of experimental methods or results. Flowchart of the search processes was as shown in Figure 1.


SubjectsLocationAcupointInterventionTime of interventionSignal pathwayMain resultsAuthor, reference

Male, SD rats, MCAObrainGV20EA, 3mA, 2/20Hz30min, QOD for 14 daysincrease expression of BDNF/TrkBelevation of BDNF
neuron proliferation
Kim MW, et al. 2012[28]

Male, postnatal SD rats, MCAOhippocampusGV20, GV14EA, 2Hz20min, QD for 10 daysincrease VEGF and BDNF levelsproliferation and differentiation of neuronal stem cellsKim YR, et al. 2014[27]

Male, postnatal SD rats, CCAOhippocampusGV20, Ex-HN 1MA, 2Hz for 15 sec30min/time, 3 timesincrease GDNF and BDNF levelsantiapoptosisZhang Y, et al. 2015[19]

Either sex, SD rats, CCAO combination with hypoxic treatmentcerebral cortexMA: GV 20, GV 14, LI 11, KI 1
EA: GV 14, LI 11
MA and EA, 1mA, 1/20 Hz10 min, QDactivation of GDNF/RET/Akt pathwayneuroprotectionXu T, et al. 2016[25]

Male, SD rats, MCAObrainGV20EA, 1 mA, 2/15 Hz30minactivation of ERK1/2 pathwayelevation of CB1
neuroprotection
Du J et al. 2010[32]

Male, SD rats, MCAObrainST36, LI11EA, 1/20 Hz30 min, QDactivation of the ERK pathwayelevation of Ras, cyclin D1 and CDK4
neural cell proliferation
Xie G, et al. 2013[33]

Male, SD rats, MCAObrainGV 20, GV14EA,2.7-3.0 mA, 5Hz25min, QD for 2 daysactivation of MAPK/ERK kinase, ERK1/2 pathwayelevation of BDNF, pRaf-1, pp90RSK, pBad
depression of caspase-3 protein
neuroprotection
Cheng CY, et al. 2014[34]

Male, SD rats, MCAObrainLI11, ST36EA, 1-20 Hz30min, QD for 3 daysactivation of the ERK1/2 pathwayelevation of p21 or p27
depression of cyclin D1, CDK4, cyclin E and CDK2
neural cell proliferation
Huang J, et al. 2014[29]

Male, SD rats, MCAOhippocampusLU5, LI4, ST36, SP6EA, 2mA, 2/15 Hz20 min, QD for 3 daysactivation of the ERK pathwayantiapoptosisWu C, et al. 2015[35]

Male, SD rats, MCAObrainLU5, LI4, ST36, SP6EA,2 mA, 2/15Hz20min, QD for 3 days and 7 daysactivation of ERK pathwayantiapoptosisWu C, et al. 2017[36]

Male, SD rats, ligation of common carotid artery and external carotid arteryhippocampusLU5, LI4, ST36, SP6EA, 2/50 Hz20 min, QDregulation of p38 MAPK signal pathwaydepression of phosphorylated p38 MAPK
antiapoptosis
Lan X, et al. 2017[41]

Male, SD rats, MCAObrainGV20, GV14, GV26MA30min/time, 7 timesInactivation of MAPK/ERK pathwayelevation of Bcl-2
depression of Bax
anti-apoptosis
Lin Y, et al. 2017[42]

Male, SD rats, MCAObrainLI11, ST36EA, 1mA, 4/20 Hz30min, QD for 3 daysmodulation of ERK/JNK/p38 signal pathwayelevation of caspase-3, growth factor midkine
depression of Bcl-2
anti-apoptosis
Xing Y, et al. 2018[43]

Male, SD rats, MCAObrainGV20, GV24EA, 1mA, 1/20 Hz30 min, QD for 10 daysmodulation of p38MAPK/ERK1/2/JNK pathwayelevation of ERK1/2, Bcl-2/Bax ratio
depression of JNK, p38 MAPK
anti-apoptosis
Liu J, et al. 2018[44]

Male, SD rats, MCAOsensorimotor cortexLI11, ST36EA, 0.2mA, 1/20Hz30 min, QD for 3 daysinactivation of NF-κB, p38 MAPK and MYD88 pathwaydepression of TNF-α, IL-1β, IL-6
inhibition of microglia-mediated neuroinflammation
Liu W, et al. 2016[45]

Male, SD rats, MCAObrainGV20, GV16EA, 5 Hz and 25Hz25 min, QDactivation of p38 MAPK/CREB pathwaydecrease reactive astrocytosisCheng CY, et al. 2015[46]

Male, Wistar rats, homologous blood emboli injection of internal carotid arteryhippocampusST36MAQD for 14 daysactivation of cAMP/PKA/CREB pathwayactivation of long-term potentiationLi QQ, et al. 2015[47]

Male, SD rats, MCAOhippocampusGV24, GV20EA, 1-3mA, 5/20Hz30min, QDincrease expression of p-CREBelevation of superoxide dismutase and glutathione peroxidase, Bcl-2
depression of malondialdehyde, Bcl2-xl
anti-oxidase
anti-apoptosis
Lin R, et al. 2015[48]

Male C57BL/6 mice, bilateral stenosis of the common carotid arterycorpus callosumGV20, GV14EA, 2Hz20min, QD for 7 daysp-CREB pathwayoligodendrocyte regenerationAhn SM, et al. 2016[49]

Female, SD rats, MCAOhippocampusGV20, GV24EA, 1/20Hz30min, QD for 7 daysinactivation of CaM-CaMKIV-CREB pathwayinactivation of CaM-CaMKIV-CREB pathwayZhang Y, et al. 2016[50]

Male, SD rats, MCAOhippocampusGV20, HT7MA
LA, 30 mW, 100Hz
14 daysenhance cholinergic systemelevation of CREB, BDNF, and Bcl-2
depression of Bax
anti-apoptosis
Yun YC, et al. 2017[51]

Neonatal SD rats, CCAObrainGV20, ST36EA, 1mA, 2Hz20minactivation of CREB/BDNF pathwayoligodendrogenesisPak ME, et al. 2018[52]

Male, Wistar rats, MCAOforebrainGV20, GV26EA, 3mA, 3/20Hz60minactivation of Aktdepression of caspase-9
anti-apoptosis
Wang SJ, et al. 2002[55]

Male, SD rats, MCAObrainGV26, CV 24,EA,1 mA, 4/16Hz30minactivation of PI3K pathwayneuroprotectionSun N, et al. 2005[56]

Male, SD rats, MCAObrainGV26, CV24EA, 4/16Hz30 minactivation of TrkA-PI3K pathwayneuroprotectionZhao L, et al. 2007[57]

Rats, modified intravascular suture techniquehippocampus, cerebral cortexGV26, CV 24acupuncture--activation of TrkA/PI3K pathwaydepression of NO, nNOS and iNOSChen SX, et al. 2011[58]

Male, SD rats, MCAObrainLI11, ST36EA, 1mA, 1/20 Hz30 min, QDactivation of PI3K/Akt pathwayelevation of BDNF, GDNF, Bcl-2/Bax ratio
anti-apoptosis
Chen A, et al. 2012[59]

SD rats, left common carotid artery (LCCA) ligationcerebral cortexGV 20, GV 14, LI 11, KI 1MA and EA--activation of PI3K/Akt pathwayneuroprotectionXu T, et al. 2014[60]

Male, SD rats, MCAObrainLI11, ST36EA, 4/20 Hz30 min, QD for 3 daysactivation of PI3K/Akt pathwayelevation of PI3K, p-Akt, p-Bad and Bcl-2
depression of Bax, caspase-3-positive expression
anti-apoptosis
Xue X, et al. 2014[12]

Male, SD rats, MCAObrainGV20, CV6EA,1mA, 2Hz30min, BIDactivation of PI3K/Akt pathwaydepression of caspase-3, -8 and -9
anti-apoptosis
Kim YR, et al. 2013[61]

Male, SD rats, MCAObone marrowGV20, LI4, LR3EA, 3mA, 2/20Hz30min, QDincrease expression of p-Akt proteinelevation of CD 34+ endothelial progenitor cellXie CC, et al. 2014[63]

Male, SD rats, MCAObrainLI11, ST36EA, 0.2 mA, 1/20 Hz30 min, QD for 3 daysactivation of mTORC1-ULK1 complex-beclin1 pathwaydepression of microtubule-associated protein 1 light chain 3 beta II/I, ULK1, autophagy related gene 13 and Beclin1
anti-autophagy
Liu W, et al. 2016[62]

Male, SD rats, MCAObrainGV20EA, 1mA, 2/15 Hz30 min, QD for 3 daysphosphorylation of GSK-3βanti-apoptosisWei H, et al. 2014[64]

Male, SD rats, MCAObrainGV20EA, 1mA, 2/15Hz30min, QD for 5 daysdecrease expression of p-Aktelevation of claudin-5, occludin
decrease blood-brain barrier disruption
Zou R, et al. 2015[65]

Male, SD rats, MCAObrainGV20, GV24EA 1/20Hz30min, QD for 10 daysinhibition of NF-κB-mediated apoptosis pathwaydepression of Bax and Fas
anti-apoptosis
Feng X, et al. 2013[66]

Male, SD rats, MCAObrainLI11, ST36EA,0.01mA, 1/20Hz--regulation of TLR4/NF-κB pathwaydepression of TNF-α, IL-1β and IL-6
neuroprotection
Lan L, et al. 2013[67]

Abbreviations
--: not mentioned; Bax: Bcl-2 associated X; Bad: Bcl-2-associated death promoter; Bcl-2: B-cell lymphoma 2; BDNF: brain-derived neurotrophic factor; CaMK: Ca2+/calmodulin-dependent protein kinase; cAMP: cyclic adenosine monophosphate; CB1: cannabinoid receptor type 1; CCAO: occlusion of common carotid artery; CDK: cyclin-dependent kinase; CREB: phosphorylated cyclic AMP response element-binding protein; EA: electroacupuncture; ERK: extracellular signal-regulated kinase; GDNF: glial-derived neurotrophic factor; IL: interleukin; JNK: c-Jun N-terminal kinases; MA: manual acupuncture; MAPK: mitogen-activated protein kinases; MCAO: occlusion of MCA; mTOR: mammalian target of rapamycin; MYD88: myeloid differentiation primary response 88; NF-κB: nuclear factor kappa-light-chain-enhancer of activated B cells; p38 MAPKs: p38 mitogen-activated protein kinases; PI3K: phosphatidylinositol-4,5-bisphosphate 3-kinase; PKA: protein kinase A; pp90RSK: phospho-90 kDa ribosomal S6 kinase; QD: daily; QOD: every other day; SD rat: Sprague Dawley rat; TLR4: Toll-like receptor 4; TNF-α: tumor necrosis factor-alpha; Trk: tyrosine receptor kinase; ULK: UNC-51-like kinase; VEGF: vascular endothelial growth factor.

SubjectsLocationAcupointInterventionTime of interventionSignal pathwayMain resultsAuthor, reference

Male, Wistar ratsbrainGV20, GB7MA30min, QD for 1,2,3,7,10 daysincrease GDNF level and modulate VEGF levelelevation of GDNF, VEGF (early)
depression of VEGF (late)
modulate neuron remodeling
Zhang GW, et al. 2012[72]

Male, SD rats, collagenase-induced ICHright globus pallidusST36EA,2-20Hz30min, QD, 14 daysactivation of Ang-1 and Ang-2elevation of Ang-1 and Ang-2
neuroprotection
Zhou HJ, et al. 2014[73]

Male, SD rats, autologous blood-induced ICHright caudate nucleusGV20, GB7MA, 3-4Hz, 5min30min, QD, 7 daysinactivation of TNF pathwaydepression of TNF-α and NF-κB
anti-inflammation
Liu H, et al. 2017[74]

Male, SD rats, collagenase-induced ICHright caudate nucleusGV20, GB7EA,0.2mA, 2Hz30min, QD, 1,3,7 daysactivation of caveolin-1/matrix metalloproteinase/blood-brain barrier permeability pathwayelevation of caveolin-1, matrix metalloproteinase-2/9
reduce blood-brain barrier permeability
Li HQ, et al. 2016[75]

Male, SD rats, collagenase and heparin-induced ICHright caudate putamenGV20, GV14EA,1mA, 3Hz10min, QD, 14 daysactivation of Bcl-2 pathwayelevation of Bcl-2 protein
depression of caspase-3 and Bax proteins
increase absorption of hematoma and anti-apoptosis
Zhu Y, et al. 2017[76]

Male, Wistar rats, autologous blood-induced ICHcaudate nucleusPC6, GV26EA, 4Hz1minbalance of BCL-2 and Baxelevation of BCL-2 mRNA
depression of Bax mRNA
anti-apoptosis
Li Z, et al. 2017[77]

Abbreviations
--: not mentioned; Ang: Angiopoietin; Bax: Bcl-2 associated X; Bcl-2: B-cell lymphoma 2; EA: electroacupuncture; GDNF: glial-derived neurotrophic factor; ICH: intracranial hemorrhage; MA: manual acupuncture; NF-κB: nuclear factor kappa-light-chain-enhancer of activated B cells; QD: daily; SD rat: Sprague Dawley rat; TNF-α: tumor necrosis factor-alpha; VEGF: vascular endothelial growth factor.

SubjectsLocationAcupointInterventionTime of interventionSignal pathwayMain resultsAuthor, reference

Male, SD rats, lithium-pilocarpine injectiondentate gyrusST36EA, 1-20mA, 4/20Hz30min, QD for 30,45,60 daysactivation of GAD 67elevation of GAD67 mRNA
anti-epileptic
Guo J, et al. 2008[85]

Male, SD rats, kainic acid injectionprefrontal cortex, hippocampus, and somatosensory cortexauricular acupointAuricular EA, 2 and 15Hz20min, QD, 3 days/wk for 3 wksinactivation of TLR 4 pathwaydepression of pCaMKIIα, pERK, pp38, pJNK, pNFκB
anti-epileptic
Liao ET, et al. 2018[94]

Male, SD rats, intraperitoneal injection of pentylenetetrazolhippocampal CA 1 and CA 3GV20, GV14MAQD for 5 daysactivation of PI3 K/Akt pathwayincrease pyramidal cellsYang, F, et al. 2013[95]

Male, SD rats, kainic acid injectionhippocampal CA1 areasAuricular acupointEA, 2Hz20min, 3 days/wk for 6wksInactivation of TRPA1, pPKCα, pPKCε, and pERk1/2 pathwayselevation of PKCα
depression of TRPA1, PKCε, pERK1/2
anti-epileptic
Lin YW, et al. 2014[93]

Male, SD rats, intraperitoneal injection of pentylenetetrazolhippocampal CA 1 regionGV20, GV14MA30minbalance of GRP78 and CHOPelevation of GRP 78 protein
depression of CHOP
neuroprotection
Yang F, et al. 2014[96]

Male, newly-born SD rats, pentylenetetrazol intraperitoneal injectionhippocampusGV20, GV14MAQD for 7 daysbalance of GRP78 and CHOPelevation of GRP 78 protein
depression of CHOP, caspase-12
anti-apoptosis
Zhang, H, et al. 2017[97]

Abbreviations
Akt: protein kinase B; CaMK: Ca2+/calmodulin-dependent protein kinase; CHOP: C/-EBP homologous protein; COX: cyclooxygenase; EA: electroacupuncture; ERK: extracellular signal-regulated kinase; GAD67: glutamic acid decarboxylase 67; GRP78: glucose-regulated protein 78; IL: interleukin; JNK: c-Jun N-terminal kinases; MA: manual acupuncture; NF-κB: nuclear factor kappa-light-chain-enhancer of activated B cells; p38 MAPKs: p38 mitogen-activated protein kinases; PI3K: phosphatidylinositol-4,5-bisphosphate 3-kinase; PKC: protein kinase C; QD: daily; QOD: every other day; SD rat: Sprague Dawley rat; TLR4: Toll-like receptor 4; TNF-α: tumor necrosis factor-alpha; TRPA: transient receptor potential ankyrin 1.

SubjectsLocationAcupointInterventionTime of interventionSignal pathwayMain resultsAuthor, reference

SD rats, CUMShippocampus, frontal cortexGV20, EX-HN3, PC6--QOD for 28 daysactivation of BDNF pathwayelevation of BDNF mRNA and protein
neural regeneration
Liang J, et al. 2012[104]

Male, SD rats, CUShippocampusLI4, LR3EAQD for 21 daysregulation of soluble N-ethylmaleimide-sensitive factor attachment receptor proteinsdepression of SNAP25, VAMP1, VAMP2, VAMP7, and syntaxin1Fan L, et al. 2016[106]

SD rats, CUMShippocampusGV20, EX-HN3EA, 0.6mA, 2Hz20min, QD for 21 daysactivation of NO-cGMP pathwayelevation of nNOS, cGMP
normalize activity of the NO/cGMP pathway
Han YJ, et al. 2009[107]

Male, SD rats, CUShippocampusGV20, PC6--QD for 28 daysInactivation of NF-κB inflammatory pathwaydepression of NF-κB, COX-2, prostaglandin
inhibition of pro-inflammatory pathway
Shao RH, et al. 2015[108]

Male, SD rats, CUMShippocampus, prefrontal cortexGV20, PC6MA, rotated 2Hz for 1 min and retained10min, QOD for 28 daysactivation of ERK-CREB pathwayelevation of ratio of p-ERK1/2 to ERK1/2, ratio of p-CREB to CREB
influence BDNF expression
Lu J, et al. 2013[109]

Male, SD rats, CUMShippocampusGV20, GB34EA, 0.3mA, 2/100Hz30min, QD for 14 daysactivation of ERK pathwayelevation of p-ERK
neural stem cells proliferation
Yang L, et al. 2013[110]

Male, SD rats, CUMShippocampusGV20, EX-HN3EA, 1-3mA, 2Hz15 min, QD for 14 daysmodulation of the p-ERK1/2 and p-p38MAPK pathwayelevation of p-ERK1/2, p-p38Xu J, et al. 2015[111]

Male, SD rats, CUMShippocampusGV20, GV29MA, 2Hz for 1min10min, QD for 21 daysactivation of ERK pathwayelevation of -ERK1/2, CREB, and p-CREB
neurotrophy and neurogenesis
Zhang X, et al. 2016[112]

Male, SD rats, CUMShippocampusGV20, GV29EA, 0.6mA, 2Hz20min, QD for 21 daysActivation of MAPK/ERK pathwayelevation of BDNF, ERK, pERK, ribosomal s6 kinase
augmentation of BDNF pathway, neurogenesis, anti-apoptosis
Li W, et al. 2017[113]

Male, specific pathogen-free SD rats, CRShippocampusGV20, GV29EA, 1mA, 2Hzpre-stress, 20min, QD for 28 daysmodulation of MAPK/ERK pathwayelevation of MAPT
depression of PKC
inhibition of cell differentiation and proliferation
Yang X, et al. 2017[114]

Male, SD rats, CUMShippocampusGV20, GV29EA21 daysinactivation of JNK pathwaydepression of p-JNK
anti-apoptosis
Dai W, et al. 2010[115]

Male, SD rats, CUMShippocampusGV20, GV29acupuncture20 min, QDinactivation of JNK pathwaydepression of p-JNK protein, MKK 4, MKK 7 proteinGuo Y, et al. 2016[116]

Male, SD ratshippocampus, serumGV20, EX-HN1, ST36, ST40EAQOD for 21 daysregulation of hypothalamus-pituitary-adrenal axiselevation of cortisol, PKA, PKCLu F, et al. 2008[117]

Male, SD rats, chronic mild stresshippocampusLI4, LR3EA, 2/20 Hz30min, QOD for 42 daysactivation of AC-cAMP-PKA pathwayactivation of AC-cAMP-PKA pathwayLiu JH, et al. 2012[118]

Male, SD rats, CUMShippocampusGV20, EX-HN3EA, 0.6mA, 2Hz30min, QD for 14, 28 daysactivation of CREB and BDNF pathwayselevation of BDNF, TrkB, PKA, pCREB
depression of CaMKII
anti-apoptosis, neuroprotection
Duan DM, et al. 2016[119]

Male, SD rats, CUMShippocampusGV20, EX-HN3MA,pre-stress, 30min for 21 daysActivation of PKA/CREB pathwayelevation of PKA-α and p-CREBJiang H, et al. 2017[120]

Male, SD rats, Single prolonged stressHippocampus, serumHT8MA, rotate 2Hz for 30secQDactivation of mTOR pathwayelevation of corticosterone(serum), corticotropin-releasing factor, mTOR phosphorylation, Akt, ERK, p70S6K, p4E-BP-1, CREB, PSD95, Syn1, GluR1
increase synaptic plasticity
Oh JY, et al. 2018[121]

Male, Wistar rats, CUMShippocampus and serumGV20, EX-HN3EA, 1mA, 2Hz, pre-stress60min, QD for 28 daysRegulation of neurotrophin signaling pathway, MAPK/ERK pathway and PI3K/Akt pathwaydepression of miR-383-5p and miR-764-5p
activation of neurotrophy and inhibition of abnormal apoptosis
Duan DM, et al. 2017[122]

Male, SD rats, CRShippocampusGV20, EX-HN3not mentioned20min, QD for 28 daysdown regulation of toll-like receptor signalling pathway and nucleotide-binding oligomerization domain-like receptor pathwayregulating inflammatory response, innate immunity and immune responseWang Y, et al. 2017[123]

Male, SD rats, CRSfrontal cortexGV20, GV29MApre-stress, 20min, QD for 28 daysToll-like receptor pathway, TNF pathway, NF-κB pathwayinhibition of inflammatory processWang Y, et al. 2017[124]

Abbreviations
AC: adenyl cyclase; Akt: protein kinase B; BDNF: brain-derived neurotrophic factor; CaMK: Ca2+/calmodulin-dependent protein kinase; cAM: cyclic adenosine monophosphate; cGMP: cyclic guanosine monophosphate; COX: cyclooxygenase; CREB: phosphorylated cyclic AMP response element-binding protein; CRS: chronic restraint stress; CUMS: chronic unpredictable mild stress; CUS: chronic unpredictable stress; EA: electroacupuncture; ERK: extracellular signal-regulated kinase; JNK: c-Jun N-terminal kinases; MA: manual acupuncture; MAPK: mitogen-activated protein kinases; MAPT: microtubule-associated protein Tau; mRNA: messenger ribonucleic acid; mTOR: mammalian target of rapamycin; NF-κB: nuclear factor kappa-light-chain-enhancer of activated B cells; nNOS: neuronal nitric oxide synthase; NO: nitric oxide; p38 MAPKs: p38 mitogen-activated protein kinases; PKA: protein kinase A; PKC: protein kinase C; QD: daily; QOD: every other day; SD rat: Sprague Dawley rat; TrkB: tyrosine receptor kinase B; VAMP: vesicle-associated membrane protein.

SubjectsLocationAcupointInterventionTime of interventionSignal pathwayMain resultsAuthor, reference

Male, SD rat, scopolamine injectionbrainGV20MApretreatment for 5 min, QD for 14 daysenhance cholinergic system-CREB-BDNF pathwayelevation of choline acetyltransferase, choline transporter 1, vesicular acetylcholine transporter, BDNF, CREB proteins
neuroprotection
Lee B, et al. 2014[135]

APP/PS1 micebrainGV20EA, 1/20 Hz30min, QD for 4 weeksmodulation of BDNF-TrkB pathwayelevation of BDNF/proBDNF ratio, p-TrkB
depression of β-amyloid (1-42), p75
anti-apoptosis
Lin R, et al. 2016[136]

Male, SAMP10hippocampusCV17, CV12, CV6, ST36, SP10MAQDregulation of aging geneelevation of p53, Mad related protein 2, Nucleoside diphosphate kinase B, AT motif-binding factor, Hsp84, Hsp86
depression of p38 MAPK, retinoblastoma-associated protein 1
anti-oxidation
Ding X, et al. 2006[18]

SD rat, Aβ1-40 injectionhippocampus, frontal cortexGV20, KI3, ST36EA, 1mA, 2Hz15min, QD for 12 daysinactivation of p38 MAPK pathwaydepression of p-p38 MAPK protein, IL-1beta mRNA
decrease neuroinflammation
Fang JQ, et al. 2013[137]

Male, SD rat, Aβ1-40 injectionhippocampus CA1GV20, BL23EA, 2mA, 2-4V, 2Hz20min, QD, 6 days/ wk for 4 weeksactivation of PPAR-γ pathwayelevation of PPAR-γ
depression of p-p38MAPK, Aβ, p-Tau Ser404 protein
decrease neuroinflammation
Zhang M, et al. 2017[138]

SAMP 10 miceneocortex and hippocampusCV17, CV12, CV6, SP10, ST36not mentionedQD for 14 daysp 130 pathwayelevation of p130
cell proliferation
Liu T, et al. 2008[139]

Male, SAMP8 micecortex and hippocampusCV17, CV12, CV6, ST36, SP10MA, >2Hz30sec per acupoint, QD, 21 daysregulation of G protein/ IP3/ Ca2+ amplitude pathwayelevation of physiologically coupled activation rate and maximal coupled activation rate of Gαs and Gαi
signal homeostasis
Luo B, et al. 2017[140]

Male, APP/PS1 micebrainGV20EA, 1mA, 2/15Hz30min, QD, 5 days/wk for 4 weekssuppression of astrocytic NDRG2 pathwaydepression of Glial fibrillary acidic protein, NDRG2
increase astrocytic reactivity
Wang F, et al. 2014[141]

telomerase-deficient mice(TERC-/-) micehippocampus and dentate gyrusST36MA30 min, QD for 4 daysactivation of BDNF pathwayelevation of BDNF, TrkB, p75NTR, Akt, and ERK1/2
increase telomerase activity
Lin D, et al. 2015[142]

SD rat, beta-amyloid (Abeta)(1-40) injectionhippocampalLI20, EX-HN3EA, 1-3mA, 80-100Hz10min, QD, 5 days/wk for 6 weeksregulation of Bcl-2/Baxelevation of Bcl-2
depression of Bax
anti-apoptosis
Liu ZB, et al. 2011[143]

Male, SD rat, Aβ1-40 injectionhippocampus CA1GV20, BL23EA, <2mA, 20Hz30 min, QD, 6 days/ wk for 4 weeksdownregulation of Notch pathwayelevation of Bcl-2, synapsin-1, synaptophysin
depression of Bax, Notch1 mRNA, Hes1 mRNA
anti-apoptosis
Guo HD, et al. 2015[144]

Male, APP/PS1 micehippocampusGV20, KI1EA, 1mA, 2/100Hz15min, QD for 3 daysinactivation of caspase-3/ Bax pathwayelevation of Bcl-2/Bax ratio
depression of caspase-3-positive cell number and Bax protein
anti-apoptosis
Li XY, et al. 2016[145]

APP/PS1 micehippocampus, cortexGV20EA, 1/20Hz30min, QD, 5 days/wk for 4 weeksregulation of AMPK/mTOR pathwayelevation of GLUT1, GLUT3, p-AMPK, p-Akt, mTOR
decrease Aβ (1-42) deposition, decrease autophagy process
Liu W, et al. 2017[148]

Male, SAMP8 micehippocampus CA1GV14, BL23EA, 1mA, 2Hz20min, QD, 8 days’ treatment and 2 days’ rest for 3 cyclesactivation of AMPK pathwayelevation of p-AMPK
balance energy metabolism and improved cognitive impairment
Dong W, et al. 2015[20]

Male, SAMP8 micehippocampus and frontal cortexGV14, BL23EA, 1mA, 2Hz20min, QD, 8 days’ treatment and 2 days’ rest for 3 cyclesactivation of SIRT1-dependent PGC-1α expression pathwayelevation of ATP levels, SIRT1, PGC-1α
depression of PGC-1α acetylation
improved brain energy metabolism
Dong W, et al. 2015[151]

Abbreviations
Akt: protein kinase B; AMPK: AMP-activated protein kinase; APP/PS1: amyloid precursor protein (APP)/presenilin-1 (PS1) double transgenic; Bax: Bcl-2 associated X; Bcl-2: B-cell lymphoma 2; BDNF: brain-derived neurotrophic factor; CREB: phosphorylated cyclic AMP response element-binding protein; EA: electroacupuncture; ERK: extracellular signal-regulated kinase; GLUT: glucose transporter; IL: interleukin; IP3: Inositol triphosphate; MA: manual acupuncture; MAPK: mitogen-activated protein kinases; NDRG2: N-myc downregulated gene 2; NMDA: N-methyl-D-aspartate; PGC1: proliferator-activated receptor γ coactivator 1; PPAR-γ: peroxisome proliferator-activated receptors γ; QD: daily; QOD: every other day; RBL2: Retinoblastoma-like protein 2; SAMP: senescence-accelerated mouse prone; SD rat: Sprague Dawley rat; SIRT1: sirtuin 1; TrkB: tyrosine receptor kinase B.

SubjectsLocationAcupointInterventionTime of interventionSignal pathwayMain resultsAuthor, reference

Male, Wistar rats, homologous blood emboli injection of internal carotid arteryhippocampusST36MAQD for 14 daysactivation of cAMP/PKA/CREB pathwayactivation of long-term potentiationLi QQ, et al. 2015[47]

Male, SD rats, MCAOhippocampusGV24, GV20EA, 1-3mA, 5/20Hz30min, QDincrease expression of p-CREBelevation of superoxide dismutase and glutathione peroxidase, Bcl-2
depression of malondialdehyde, Bcl2-xl
anti-oxidase and anti-apoptosis
Lin R, et al. 2015[48]

Female, SD rats, MCAOhippocampusGV20, GV24EA, 1/20Hz30min, QD for 7 daysinactivation of CaM-CaMKIV-CREB pathwayanti-apoptosisZhang Y, et al. 2016[50]

Male, SD rats, MCAOhippocampusGV20, HT7MA, LA, 30 mW, 100Hz14 daysenhance cholinergic systemelevation of CREB, BDNF and Bcl-2
depression of Bax
anti-apoptosis
Yun YC, et al. 2017[51]

Mongolian gerbils, CCAOhippocampal CA1KI3, GV20EA, 1mA, 2Hz20 min, 4 times/ 2 daysregulate MAPK/ERK pathwayelevation of p-ERK
depression of ionized calcium-binding adaptor molecule 1, TLR4, TNF-α
decrease neuroinflammation, regulate the synaptic plasticity
Yang EJ, et al. 2016[153]

Male Wistar rats, two-vessel occlusion modelhippocampusGV20, ST36MAQD for 14 daysinactivation of ASK1-JNK/p38 pathwayelevation of thioredoxin-1 and thioredoxin reductase-1
anti-oxidase and anti-apoptosis
Zhu W, et al. 2018[154]

Male, Wistar rat, homoblood injectionhippocampal CA1CV17, CV12, CV6, ST36, SP10MA, 2Hz30sec for each acupoint, QD, 6 days/ wk for 3 weeksbalance Bcl-2 and Bax expressionelevation of Bcl-2
depression of Bax
anti-apoptosis
Wang T, et al. 2009[155]

Male, SD rat, using modified Pulsinelli 4-vessel-occlusion methodhippocampal CA1Scalp-acupunctureMA30min, QD for 10 daysactivation of Bcl-2 pathwayelevation of Bcl-2
anti-apoptosis of astrocytes
Tian WJ, et al. 2015[156]

Female, SD rat, CCAOhippocampusGV20, GV14, BL23EA, 2mA, 4Hz30min, QD for 30 daysactivation of mTOR pathwayelevation of mTOR and eIF4E
modulates cell growth, proliferation and synaptic plasticity
Zhu Y, et al. 2013[157]

Abbreviations
ASK1: apoptosis signal-regulating kinase 1; Bax: Bcl-2 associated X; Bcl-2: B-cell lymphoma 2; BDNF: brain-derived neurotrophic factor; CaMK: Ca2+/calmodulin-dependent protein kinase; cAMP: cyclic adenosine monophosphate; CCAO: occlusion of common carotid artery; CREB: phosphorylated cyclic AMP response element-binding protein; EA: electroacupuncture; eIF4E: eukaryotic translation initiation factor 4E; ERK: extracellular signal-regulated kinase; JNK: c-Jun N-terminal kinases; MA: manual acupuncture; MAPK: mitogen-activated protein kinases; MCAO: occlusion of middle cerebral artery; mTOR: mammalian target of rapamycin; PKA: protein kinase A; QD: daily; TLR4: Toll-like receptor 4.

SubjectsLocationAcupointInterventionTime of interventionSignal pathwayMain resultsAuthor, reference

Male SD rats, rotenone injectionsubstantia nigraGV16, LR3EA, 1mA, 2Hz20min, QD for 14 daysinactivation of p38-MAPK pathwayelevation of tyrosine hydroxylase-positive neuron
depression of phosphorylated p38-MAPK, COX-2
decrease neuroinflammation
Wang SJ, et al. 2013[158]

Male SD rats, rotenone injectionsubstantia nigraGV16, LR3EA, 2mA, 2Hz20min, QD for 14 daysinactivation of ERK 1/2 pathwayelevation of tyrosine hydroxylase protein
depression of p-ERK 1/2, TNF-α, IL-1β
decrease neuroinflammation
Wang SJ, et al. 2014[159]

Male C57BL/6 mice, MPTP injectionsubstantia nigra, striatumGB34MA, 2Hz for 15secQD for 7 daysactivation of PI3K/Akt pathwayelevation of pAkt
prevents MPTP-induced dopaminergic neuron degeneration
Kim SN, et al. 2011[160]

Male C57BL/6 mice, MPTP injectionsubstantia nigra pars compacta, striatumGB34MA, 2Hz for 15secQD for 12 daysactivation of PI3K/Akt pathwayelevation of dopamine
depression of dopamine- and cAMP-regulated phosphoprotein of 32 kDa, Fos
increase dopamine turnover rate
Kim SN, et al. 2011[161]

Male, C57BL6 mice (MPTP intraperitoneal injection) and SD rats (Sigma-Aldrich injection into substantia nigra)substantia nigraGB34, LR3EA, 1mA, 50HzQD for 5(mice)/7(rats) daysactivation of Akt pathwayelevation of BDNF, Bcl-2, tyrosine hydroxylase
regulation of cell cycle
Lin JG, et al. 2017[162]

Imprinting control region mouse pups, systemic 6- hydroxydopamine injectionhippocampusKI3EA, 1mA, 2Hz15min, QD, 5 days/wk for 6wksinactivation of pPKA/pPKC/CaMKIIα signaling pathwaysdepression of pNR1, pNR2B, pPKA, pPKC, pCaMKIIα, pERK, pCREB
reduce neuronal excitotoxicity
Lu KW, et al. 2017[163]

Male C57BL/6 mice, MPTP injectionsubstantia nigra par compactaGB34MA, 2Hz for 15sec every 5min10min, QD for 7 daysm-TOR independent pathwaydepression of α-synuclein
induces autophagic clearance of α-syn, dopaminergic neurons protection
Tian T, et al. 2016[164]

Male C57BL/6 mice, MPTP injectionsubstantia nigra, striatumGB34, GB39EA, 1mA, 100Hz20min, QD for 12 daysregulation of glyoxalase systemelevation of tyrosine hydroxylase-positive neurons, cytochrome c oxidase subunit Vb
depression of cytosolic malate dehydrogenase, munc18-1, hydroxyacylglutathione hydrolase
anti-oxidative effect
Kim ST, et al. 2010[165]

Male C57BL/6 mice, MPTP injectionmidbrain, striatumST36, SP6EA, 1-1.4mA, 100Hz30min, QD for 12 days, except day 7activation of Nrf2-ARE pathwayelevation of tyrosine hydroxylase, ARE-driven reporter gene, NQO1, HO-1
depression of ionized calcium-binding adaptor molecule 1, TNF-α, IL-6, IL-1β
anti-oxidative effect
Lv E, et al. 2015[166]

GFAP-tTA/tetO-α-syn double transgenic micemidbrain, striatumST36, SP6EA, 1-1.2mA, 100Hz30min, QD for 28 daysactivation of Nrf2-ARE pathwayelevation of Nrf2, HO-1, glutamate-cysteine ligase modifier subunits
depression of α-syn
decrease astrogliosis and neuroinflammation
Deng J, et al. 2015[167]

Male C57BL/6 mice, MPTP injectionstriatum, substantia nigraGB34MA, 2Hz, 15secQD for 12 daysactivation of p53 signaling pathwayselevation of p53
dopaminergic neuron protection
Park JY, et al. 2015[168]

Abbreviations
Akt: protein kinase B; ARE: antioxidant response element; CaMK: Ca2+/calmodulin-dependent protein kinase; cAMP: cyclic adenosine monophosphate; COX: cyclooxygenase; CREB: phosphorylated cyclic AMP response element-binding protein; EA: electroacupuncture; ERK: extracellular signal-regulated kinase; HO-1: heme oxygenase-1; IL: interleukin; MA: manual acupuncture; MPTP: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; mTOR: mammalian target of rapamycin; NQO1: nicotinamide adenine dinucleotide phosphate quinone oxidoreductase; Nrf2: nuclear factor erythroid 2-related factor 2; p38 MAPKs: p38 mitogen-activated protein kinases; PI3K: phosphatidylinositol-4,5-bisphosphate 3-kinase; PKA: protein kinase A; PKC: protein kinase C; pNR: phosphorylated N-methyl-D-aspartate receptor; QD: daily; SD rat: Sprague Dawley rat; TNF-α: tumor necrosis factor-alpha.

3. Cerebral Ischemic Injury

Ischemic injury of the brain, also known as cerebral infarction, is a crucial health issue in the modern world because of its associated disability and socioeconomic burden. Acupuncture has shown beneficial effects on ischemic stroke rehabilitation by exerting the antiapoptosis effect on the ischemic area, promoting neurogenesis and cell proliferation, and regulating cerebral blood flow [21, 22]. A retrospective cohort study reported that acupuncture was effective at reducing the stroke recurrence rate [23]. Ischemic stroke causes neural cell damage related to excitotoxicity, oxygen free radical injury, inflammatory status, and blood-brain barrier (BBB) damage [24]. Experimental pathways that can reverse apoptosis and improve cell proliferation and differentiation have been proposed.

Acupuncture causes an increase in the expression of neurotrophic factors, such as BDNF and glial-derived neurotrophic factor (GDNF), in the central nervous system (CNS), exerts a neuroprotective effect on hypoxic-ischemic insults, and results in neurogenesis after the reconstruction phase [25, 26]. In addition, acupuncture increased the vascular endothelial growth factor (VEGF) level in the hippocampus, promoting the proliferation and differentiation of neuronal stem cells [27]. Thus, acupuncture can be used to treat ischemic injury in the brain. Zhang et al. performed manual acupuncture on GV20 and Ex-HN 1 to increase GDNF and BDNF levels in a rat model [19]. The elevation of the BDNF level was related to the increased expression of BDNF/tyrosine receptor kinase B (TrkB) and the induction of neurogenesis [28].

The mitogen-activated protein kinase (MAPK) family includes ERK1/2, JNK, and p38 MAPK proteins. In animals, the MAPK family is triggered by growth factors, stress, or an inflammatory environment and regulates cell functions, such as proliferation, division, differentiation, survival, and apoptosis. EA can trigger the MAPK family. ERK is believed to mediate reperfusion injury by inhibiting inflammatory reactions and promoting cell proliferation and growth [29]. However, equivocal results have been reported concerning the protective effect of ERK on ischemic brain injury [30, 31]. Some studies have demonstrated that EA protects against ischemic brain injury by reducing infarct volumes and improving neurological outcomes through activation of the ERK1/2 signaling pathway [29, 3234]. EA is reported to be effective in neuroprotection and neural cell proliferation. The chosen acupoints in EA include GV20, GV14, ST36, and LI11. The activation of the ERK pathway is combined with an increase in BDNF and p-ERK1/2 levels [34]. Some studies have demonstrated that the application of EA on LU5, LI4, ST36, and SP6 was effective in reducing neurogenic deficits and causing antiapoptosis in the brain cortex and hippocampus [35, 36].

Environmental stresses and inflammatory cytokines activate p38 MAPKs and induce apoptosis and inflammation [37]. In the acute phase of ischemic brain injury, the p38 MAPK signaling pathway induces neurotoxicity, whereas in the subacute phase, this pathway serves as a proinflammatory mediator in the neuroprotective antiapoptosis effect [3840]. Some studies have reported that EA exerts the antiapoptosis effect on the peri-infarct cortex by modulating the ERK/JNK/p38 MAPK signaling pathway [4144]. The chosen acupoints include GV14, GV20, GV24, GV26, LU5, LILI4, LI11, ST36, and SP6. Liu et al. reported that EA inhibits microglia-mediated neuroinflammation mediated by nuclear factor kappa-light-chain-enhancer of activated B (NF-κB) cells, p38 MAPK, and myeloid differentiation primary response 88 (MYD88), as well as simultaneously reducing cytokine tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6) levels [45].

The p38 MAPK pathway activates the expression of CREB protein and reduces the apoptosis of ischemic neural cells. Acupuncture on GV16, GV20, GV24, ST36, and HT7 also triggered the CREB pathway in the hippocampus and improved cognitive impairment in an animal model [4651]. The CREB pathway is related to BDNF, p38 MAPK, and Ca2+/calmodulin-dependent protein kinase (CaMK) [46, 50, 52]. Lin et al. reported that EA exerted antioxidant and antiapoptosis effects by increasing superoxide dismutase and glutathione peroxidase levels and reducing the malondialdehyde level in the hippocampus and improved the learning and memory ability of rats [48]. A study reported that laser acupuncture on GV20 and HT7 for 14 days excited the cholinergic system and increased CREB, BDNF, and B-cell lymphoma 2 (Bcl-2) levels, thereby improving cognitive impairment in rats [51].

Being a cell cycle initiator, PI3K/AKT pathways are essential for cell survival [53]. However, interactions between transactivation of Raf/MAPK/ERK1/2 and PI3K/AKT systems were noted during ischemia and reperfusion phases. During ischemia, Akt reduces Raf/MAPK/ERK1/2 activity through phosphorylation of Raf-1. During reperfusion, abrupt reactive oxygen species (ROS) increases the phosphatase and tensin homolog and reactivates Raf/MAPK/ERK1/2 signaling [54]. For the modulation of the PI3K pathway, some studies have reported that EA on GV12, GV20, GV24, GV26, KI1, LI11, and ST36 activates the PI3K/AKT pathway and exerts antiapoptosis and neuroprotective effects [12, 5560]. The effect of EA on the PI3K pathway can activate the downstream mTOR complex 1–UNC-51-like kinase 1 complex–Beclin-1 pathway, reduce caspase-3, caspase-8, and caspase-9 levels, and inhibit the autophagy process [61, 62]. EA also reduces nitric oxide (NO), neuronal NO synthase (nNOS), and inducible NO synthase (iNOS) levels by activating the PI3K pathway [58]. Xie et al. demonstrated that EA improved neurological deficit scores and increased the expression of p-AKT protein and bone marrow CD34+ endothelial progenitor cells in rats [63].

Because of the balance between Raf/MAPK/ERK1/2 and PI3K/AKT systems, some studies have included the pretreatment protocol [64, 65]. EA pretreatment in a rat model reduced the expression of p-Akt protein and prevented the downregulation of tight junction proteins, namely, claudin-5 and occludin, attenuating BBB disruption and brain edema [65].

NF-κB is another protein complex related to cell survival. Some studies have demonstrated that EA regulates the NF-κB-mediated apoptosis pathway and provides neuroprotection [66, 67].

Acupuncture improved neurogenic defects and cognitive impairment in a cerebral ischemic/reperfusion animal model. In summary, acupuncture not only increases the levels of neurotrophic factors but also modulates signaling pathways, such as Raf/MAPK/ERK1/2 and PI3K/AKT and downstream CREB and NF-κB. Therefore, acupuncture results in cell proliferation, antiapoptosis, neuroprotection, and BBB maintenance. The most frequently chosen acupoints include GV20, GV14, and ST36. The mechanisms and main results of identified articles are summarized in Table 1.

4. Cerebral Hemorrhagic Injury

Hemorrhagic stroke is less common than ischemic stroke. The causes of hemorrhagic stroke include high blood pressure, brain trauma, aneurysms, arteriovenous malformations, and brain tumors. In cerebral hemorrhagic injury, blood vessel spasms and oxidative stress caused by ischemia and reperfusion cause an injury to neural cells. Acupuncture could improve the hypoperfusion status and hematoma absorption, reduce brain edema, and promote neurogenesis in the brain [68]. Thus, some studies have reported that acupuncture is beneficial for treating cerebral hemorrhage because it results in functional improvements [69, 70]. Acupuncture also regulates inflammatory factors, such as IL-6, IL-1β, and NF-κB, prevents apoptosis by reducing the expression of p53 protein, and promotes neurogenesis by increasing the levels of BDNF and nerve growth factors [71].

Acupuncture increased the expression of endogenous GDNF and inhibited the early expression of VEGF, thus regulating nerve remodeling after cerebral hemorrhagic injury [72]. At the level of molecular signal transduction, acupuncture exerts a neuroprotective effect by increasing the angiopoietin level and reducing TNF-α and NF-κB levels [73, 74]. Li et al. reported that EA on GV20 and GB7 could reduce BBB permeability and improve brain edema by activating the caveolin-1/matrix metalloproteinase pathway [75]. Antiapoptosis is also an important pathway for neural preservation. Zhu et al. and Li et al. have demonstrated that EA activated the Bcl-2 pathway to increase hematoma absorption and antiapoptosis. This effect is combined with the suppression of caspase-3 and Bcl-2-associated X (Bax) proteins [76, 77]. However, the chosen acupoints were heterogeneous, including ST36, GV14, GV20, GV26, GB7, and PC6.

Taken together, acupuncture could improve neurogenic disability and reduce brain edema by increasing caveolin-1/matrix metalloproteinase levels and inducing antiapoptosis through the activation of the Bcl-2 pathway in a cerebral hemorrhagic model. The mechanisms and main results of identified articles are summarized in Table 2.

5. Seizure

Seizure is an abrupt, spontaneous, excessive, or synchronous neuronal activity in the brain that leads to various uncontrolled shaking movements or loss of consciousness. Seizure attack affects 8%–10% of the general population in their lifetimes. The recurrence of seizure results in epileptic syndrome, which affects 2%–3% of the general population [78]. Epileptic seizures can be induced by metabolic imbalance, electrolyte imbalance, encephalitis, traumatic brain injury, brain tumor, stroke, and medication [78]. During the process of an epileptic seizure, changes occur in molecular, anatomical, or circuit development, including cell death, inflammatory cytokine production, and neurotransmitter dysregulation. This process is called epileptogenesis [79]. Involvement of BDNF–TrkB signaling, the mTOR pathway, and the repressor element 1-silencing transcription factor pathway was considered to be the underlying molecular mechanism [79].

In addition to the use of medication, some studies have reported that acupuncture reduced the frequency of seizures and improved the quality of life [8082]. Some studies reported that acupuncture has effect on change of anatomical, neurotransmitter, inflammatory cytokines and molecular level. The augmentation of γ-aminobutyric acid neurotransmission, including the upregulation of glutamic acid decarboxylase 67 (GAD67), is a self-protective and anticonvulsive mechanism [83, 84]. Acupuncture reduced seizure attacks by enhancing GAD67 mRNA production in the dentate gyrus of epileptic rats [85]. Acupuncture changed the brain structure and reduced the mossy fiber sprouting in the dentate gyrus and exerted an antiepileptic effect [86]. Inflammation can increase neuronal excitability and result in the frequent onset of epilepsy, which is related to epileptogenesis [87]. Acupuncture also contributes to the antiepileptic effect accompanied by the anti-inflammatory effect of reducing IL-1β, TNF-α, and cyclooxygenase-2 (COX-2) levels in the hippocampus of an epileptic rat model [88, 89]. Wang et al. and Wang et al. have demonstrated that EA attenuated the seizure-induced increase in c-fos protein and preproenkephalin messenger ribonucleic acid (mRNA) levels in the hippocampus of a penicillin-induced seizure rat model [90, 91]. Yang et al. reported that EA on GV16 and GV8 exerted an anticonvulsant effect combined with a reduction in nNOS and iNOS levels [92].

With regard to molecular pathways, acupuncture on the auricular acupoint suppressed transient receptor potential ankyrin 1 (TRPA1) pathways by increasing the phosphorylated protein kinase C (pPKC)-α level and reducing pPKCε and pERk1/2 levels in a kainic acid-induced rat model [93]. Liao et al. used a similar rat model and reported that acupuncture exerted an antiepileptic effect by inactivating the Toll-like receptor 4 (TLR4) pathway, which was accompanied by a decrease in pCaMKIIα, pERK, pp38, pJNK, and pNFκB levels [94]. Yang et al. demonstrated that acupuncture on GV20 and GV14 reduced epileptic seizures by exerting a protective effect on the pyramidal cells of hippocampal CA 1 and CA 3. This effect was related to the activation of the PI3 K/Akt pathway [95]. The upregulation of glucose-regulated protein 78 (GRP78) and the downregulation of C/EBP homologous protein (CHOP) prevent neuronal cell death induced by endoreticulum stress. Acupuncture on GV20 and GV14 elevated the GRP78 level, reduced CHOP and caspase-12 levels, and exerted an antiapoptosis effect on the hippocampus, thus reducing epileptic seizure attacks [96, 97].

Taken together, acupuncture exerts the antiepileptic effect by changing anatomical, neurotransmitter, inflammatory cytokines and molecular level. With respect to signal transduction, acupuncture reduces seizure frequency by suppressing TRPA1/pERK and TLR4/ERK pathways and activating the PI3K/Akt pathway. Furthermore, acupuncture augments the antiapoptosis process and provides neuroprotection by increasing the GRP78 level and reducing the CHOP level. The mechanisms and main results of identified articles are summarized in Table 3.

6. Depression

Depressive disorders are common psychiatric disorders that affect approximately 17% of people in their lifetimes. A study reported that 12%–20% of depressed patients experience treatment-resistant depression, resulting in a considerable social burden [98]. In addition to medication and psychosocial support, acupuncture serves as an alternative option for patients with depression that exhibits promising effects and fewer side effects [99]. The mechanism of depression includes dysregulation of neuroinflammatory cytokines, neurotransmitters, neuroplasticity, and the neuroendocrine system [100, 101]. At the molecular level, dysregulation of striatal-enriched tyrosine protein phosphatase inactivates the neuronal signaling pathway, including ERK1/2, p38, Src family tyrosine kinases, and glutamate receptors. This process attenuates the neurogenesis effect of BDNF and causes depression [102].

Acupuncture treats depression by regulating neurotransmitters, neuroinflammatory cytokines, the hypothalamus–pituitary–adrenal axis, and the hypothalamus–pituitary–sex gland axis [103]. Furthermore, acupuncture plays a role in molecular signaling pathways. Acupuncture elevated BDNF production and excitatory amino acid transporter levels and maintained neural regeneration of the hippocampus in a depressive rat model [104, 105]. The chosen acupoints include GV20, EX-HN3, and PC6 [104, 105]. Fan et al. demonstrated that acupuncture on LI4 and LR3 regulated the expression of soluble N-ethylmaleimide-sensitive factor attachment receptor protein, a fusion mediator, and promoted depression remission [106]. NO is a small molecule that freely diffuses across cell membranes and serves as a neurotransmitter in the CNS. NO initiates the NO-cyclic guanosine monophosphate (NO-cGMP) pathway and activates protein kinases. Acupuncture regulates the NO-cGMP pathway by increasing nNOS and cGMP levels, which contribute to its effect on depression relief [107]. Shao et al. demonstrated that acupuncture on GV20 and PC6 inhibited the proinflammatory pathway of depression by reducing NF-κB protein and COX-2 levels [108].

Antidepressants alleviate the symptoms of depression by activating the MAPK/ERK pathway, which increases ERK1/2 and p-ERK1/2 expression. Many studies have reported that acupuncture activates the MAPK/ERK pathway and downstream CREB pathway and elevates BDNF production [109114]. The most commonly chosen acupoints include GV20 and GV29, followed by EX-HN3, GB34, and PC6. The MAPK/ERK pathway induces neurogenesis and antiapoptosis of hippocampal neurons and eliminates the depression state. EA on GV20 and EX-HN3 also enhances the p-p38MAPK pathway [111]. Some studies have reported that EA on GV20 and GV29 reduced the hippocampal neural apoptotic rate by downregulating the hippocampal p-JNK pathway in depression rat model [115, 116]. Acupuncture also activated the adenyl cyclase (AC)–cyclic adenosine monophosphate (cAMP)–protein kinase A (PKA)–CREB signaling pathway and elevated the BDNF level [117120]. In the AC–cAMP–PKA–CREB signaling pathway, heterogeneous acupoints were chosen, including GV20, EX-HN1, EX-HN3, ST36, ST40, LI4, and LR3.

Molecular studies have reported that acupuncture plays a role in the neuroendocrine model of depression. Lu et al. demonstrated that acupuncture could relieve the symptoms of depression and increase cortisol, PKA, and PKC levels [117]. Oh et al. reported that acupuncture on HT8 elevated the serum corticosterone level and hippocampal mTOR phosphorylation, Akt, ERK, p70S6K, p4E-BP1, and CREB enhanced the effect of BDNF on neuroprotection and synaptic plasticity. Furthermore, acupuncture elevated the levels of synaptic proteins (e.g., PSD95, Syn1, and GluR1), which are crucial for neuronal synaptic plasticity [121].

The results of the Gene Ontology functional term and Kyoto Encyclopedia of Genes and Genomes database analysis indicated that the regulation of the Toll-like receptor signaling pathway, nucleotide-binding oligomerization domain-like receptor signaling pathway, MAPK/ERK pathway, PI3K/Akt pathway, neurotrophin signaling pathway, TNF pathway, and NF-κB pathway is the mechanism through which acupuncture treats depression. The aforementioned pathways cause cell survival, differentiation, antiapoptosis, and synaptic plasticity of neurons, thus alleviating depression symptoms and improving learning/memory dysfunction [122124].

In summary, acupuncture can treat depression by upregulating MAPK/ERK and AC–cAMP–PKA–CREB pathways and downregulating JNK and NF-κB pathways. Because of the aforementioned mechanism, we observed an increase in neuron growth factor levels, neurogenesis, and antiapoptosis accompanied by the alleviation of depression symptoms. The mechanisms and main results of identified articles are summarized in Table 4.

7. Alzheimer’s Disease

AD is a progressive neurodegenerative disease that is presented with dementia, memory loss, disorientation, personality disorder, mood swings, behavior disturbance, and language problems. Because of patients’ cognitive decline, they withdraw from their family and society [125]. Risk factors for AD include genetic factors, a history of head trauma, depression, and hypertension [126]. The progression of AD is associated with the formation of amyloid plaques and neurofibrillary tangles in the brain [126]. Treatment of AD should be started immediately after the diagnosis to prevent cognitive decline. Both patients and their families are involved in administration of medication and psychosocial therapy for AD. Medication for AD includes cholinesterase inhibitors (donepezil, rivastigmine, and galantamine), N-methyl-D-aspartate receptor antagonists (memantine), atypical antipsychotics, antidepressants, and anticonvulsants [126].

In addition to medication, acupuncture has been reported to improve cognitive function and the global clinical status of patients with AD without causing major adverse effects [127, 128]. Mechanisms through which acupuncture improves cognitive impairment in AD include attenuation of Aβ deposits, upregulation of BDNF expression, and regulation of cell proliferation and neural plasticity in the brain [129131]. Acupuncture also regulates cytokine and growth factor levels associated with survival, proliferation, and differentiation of neural stem cells in the brain to promote the repair of damaged cells [130, 132].

Aβ deposits in the brain disturb BDNF signaling pathways, such as Ras/ERK, PI3K/Akt, and PKA/cAMP, which regulate BDNF expression and cause AD development [133, 134]. Acupuncture on GV20 reduces Aβ deposits in the brain, elevates the BDNF level, and exerts a neuroprotective effect on CNS cells [135, 136]. Lin et al. reported that the signaling pathway of BDNF elevation is mediated by the BDNF–TrkB pathway, which exerts an antiapoptosis effect [136]. The central cholinergic pathway is important for learning acquisition and synaptic plasticity in the mammalian limbic system; thus, increasing the acetylcholine level is a type of treatment strategy for AD. Lee et al. reported that acupuncture enhances the cholinergic system–CREB–BDNF pathway and exerts a neuroprotective effect [135].

The p38 MAPKs are activated by environmental stresses and inflammatory cytokines and induce apoptosis and inflammation. In an AD animal model, acupuncture could improve cognitive impairment by reducing p38 MAPK levels, thus reducing neuroinflammation in the CNS [18, 137, 138]. Some studies have reported using Sanjiao acupuncture, which uses CV17, CV12, CV6, ST36, and SP10, as a standard regimen for AD [18, 139, 140]. A DNA microarray analysis demonstrated that Sanjiao acupuncture could reverse gene expression profiles related to aging in the hippocampus of senescence-accelerated mouse prone 10 (SAMP10) mice and reduce oxidative stress–induced damage [18]. Luo et al. reported that Sanjiao acupuncture attenuated cognitive deficits by regulating the G-protein/inositol triphosphate/Ca2+ amplitude pathway and signal homeostasis [140]. In an Aβ-induced AD model, acupuncture on GV20 and BL23 reduced the level of peroxisome proliferator-activated receptor-γ (PPAR-γ) level and the deposition of Tau protein, thus reducing neuroinflammation [138].

Acupuncture regulated cell cycle and aging in an AD model. N-myc downregulated gene 2 (NDRG2) encodes a cytoplasmic protein that may play a role in neurite outgrowth. Wang et al. demonstrated that EA on GV20 suppressed the astrocyte NDRG2 expression and glial fibrillary acidic protein level, thereby treating memory impairment of amyloid precursor protein/presenilin-1 double transgenic mice [141]. P130, known as retinoblastoma-like protein 2 (RBL2), is a protein encoded by the RBL2 gene in humans and serves as a tumor suppressor signal. Acupuncture on CV17, CV12, CV6, SP10, and ST36 elevated the p130 level, caused cell proliferation in the brain, and treated dementia and aging-related diseases in SAMP10 mice [139]. Telomerase is a critical enzyme involved in aging and apoptosis. Lin et al. demonstrated that acupuncture on ST35 of telomerase-deficient mice activated the BDNF–TrkB signaling pathway along with elevating BDNF, TrkB, Akt, and ERK1/2 levels, which resulted in an increase in telomerase activity [142]. Acupuncture also modulates the balance of Bcl-2/Bax to regulate the cell cycle of neurons. However, the chosen acupoints were heterogeneous, including LI20, EX-HN3, GV20, BL23, and KI1 [143145].

Metabolic stress modulates β-secretase gene transcription and β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) protein levels in AD through the sirtuin 1 (SIRT1)-PPARγ-proliferator-activated receptor γ coactivator 1 (PGC-1) pathway [146]. Aβ 25–35 suppresses mitochondrial biogenesis by inactivating the AMP-activated protein kinase (AMPK)–SIRT1–PGC-1α pathway in hippocampal neurons [147]. Therefore, brain energy metabolism impairment is considered an underlying pathogenesis of AD progression. Acupuncture on GV20 elevates glucose transporter (GLUT1 and GLUT3), p-AMPK, p-AKT, and mTOR levels in the hippocampus and cortex. Through regulation of brain energy metabolism, acupuncture has effect on decreasing Aβ deposits, suppressing autophagy process and relieving cognition deficits [148]. Acupuncture improved the spatial learning and memory ability of AD mice by increasing blood perfusion and glucose uptake in the bilateral amygdala, hippocampus, and left temporal lobe [149, 150]. For the molecular signaling pathway, Dong et al. demonstrated in two series studies that acupuncture in GV14 and BL23 exerted AMPK expression, activated SIRT1-PPARγ- PGC-1 pathway, and elevated ATP level. Because of the aforementioned mechanism, acupuncture balances brain metabolism and improves cognition impairment of AD mice [20, 151]. Furthermore, the upregulation of SIRT1–PPARγ–PGC-1 suppresses BACE1 expression, thus reducing Aβ production in the hippocampus and improving cognitive decline in SAMP8 mice [152].

In summary, acupuncture treats AD by regulating neurotransmitter release, elevating the neurotrophic factor level, and exerting anti-inflammatory effects. Thus, many molecular signaling pathways involved in acupuncture were reported in the AD model, including the BDNF–TrkB pathway, the cholinergic system–CREB–BDNF pathway, G-protein regulation, and the p38 MAPK family. The aforementioned pathways are believed to exert antiapoptosis and anti-inflammatory effects and reduce Aβ deposits in the brain, thereby improving learning ability and memory in AD models. The most commonly chosen acupoints were GV20 and the Sanjiao regimen (CV17, CV12, CV6, ST36, and SP10). Acupuncture regulates cell cycle and aging by modulating NDRG2 and P130 expression, telomerase activity, and Bcl-2/Bax balance. Many studies have reported that acupuncture on GV14 and BL23 modulates brain energy metabolism impairment and treats cognitive impairment. The mechanisms and main results of identified articles are summarized in Table 5.

8. Vascular Dementia

VD, which accounts for 15% of dementia cases, is the second most common cause of dementia after AD. Multiple and recurrent ischemia of the brain caused by ischemia or hemorrhage has been found to be the main causes of VD [169]. Although the pathophysiology of VD remains unclear, approximately 15%–30% of patients develop dementia three months after the occurrence of stroke. Furthermore, approximately 20%–25% of patients develop delayed dementia [170]. Because of intricate coordination in the brain and, sometimes, the presence of other brain damage causes, the cognitive changes and declines in VD can be variable, including impairment of attention, information processing, and executive function [169]. Few medications have been approved specifically for the prevention or treatment of VD. Thus, treatment strategies for VD are similar to those for AD and include the use of cholinesterase inhibitors and memantine and providing psychosocial support.

Acupuncture can improve the scores on the Mini-Mental Status Examination, the revised Hasegawa’s dementia scale, and activities of daily living examination for VD patients [171, 172]. From the molecular viewpoint, acupuncture on GV20 and KI3 regulates the MAPK/ERK pathway by elevating the pERK level and reducing ionized calcium-binding adaptor molecule 1 (Iba-1), TLR4, and TNF-α levels [153]. Acupuncture reduced relevant proinflammatory factors, thus attenuating neuroinflammation and increasing neuronal synaptic plasticity.

Acupuncture exerted antioxidant and antiapoptosis effects in VD models. Zhu et al. reported that acupuncture on GV20 and ST36 inactivated the apoptosis signal-regulating kinase 1 (ASK1)–JNK/p38 pathway and elevated thioredoxin-1 and thioredoxin reductase-1 levels [154]. The p38 MAPK pathway activates the expression of CREB and reduces the apoptosis of ischemic neural cells. Some studies have reported that acupuncture activates the cAMP/PKA/CREB pathway and elevates the CREB level [47, 48, 50, 51]. The elevated CREB level upregulates Bcl-2 activity and downregulates Bcl-2xl and Bax activities, consequently preventing the apoptosis of neurons injured by vascular events [48, 51]. The most discussed acupoint was GV20, followed by GV24. Scalp and Sanjiao acupuncture techniques (CV17, CV12, CV6, ST36, and SP10) have been reported to affect the balance between Bcl-2 and Bax expression and antiapoptosis [155, 156]. VD rats had lower expression of mTOR and eukaryotic translation initiation factor 4E (eIF4E) in CA1 accompanied with decreased spatial memory [173]. Zhu et al. demonstrated that EA on GV20, GV14, and BL23 activates the mTOR pathway and increases mTOR and eIF4E levels, thus modulating cell growth, proliferation, and synaptic plasticity [157].

Taken together, acupuncture treats VD by activating MAPK/ERK and ASK1–JNK/p38 pathways; increasing CREB, mTOR, and Bcl-2 levels; and reducing the Bax level. In addition, through the aforementioned mechanism, acupuncture exerts an effect on antioxidant activity, antiapoptosis, and synaptic plasticity. The most commonly chosen acupoints were GV20, GV24, and ST36. The mechanisms and main results of identified articles are summarized in Table 6.

9. Parkinson’s Disease

PD is a chronic neural degenerative disorder that mainly affects the motor system. Patients with PD experience shaking, rigidity, and walking difficulty. In advanced stages of the disease, behavioral disturbance, depression, poor sleep, and cognitive dysfunction are noted [174]. Treatments such as the administration of L-dopa, dopamine agonists, catechol-O-methyl transferase inhibitors, and monoamine oxidase inhibitor and deep brain stimulation are suggested for treating motor problems of patients with PD. However, dyskinesias and motor fluctuations that develop after a long-term use or high dose use of L-dopa and nonmovement-related symptoms, such as sleep disturbances and psychiatric problems, become problems for patients with PD [174].

Both manual acupuncture and EA help alleviate some motor symptoms in patients with PD and some nonmotor symptoms, such as psychiatric disorders, sleep disorders, and gastrointestinal symptoms. Acupuncture also improved the therapeutic efficacy of levodopa, lowering the necessary dosage [175177]. Reducing dopaminergic neurons in the substantia nigra (SN) results in PD. Acupuncture has been reported to exert neuroprotective effects that increase the levels of endogenous neurotrophins and modulate the apoptosis and neuroinflammation of dopaminergic neurons in the SN [178, 179]. Neuroimaging findings of the human brain showed that acupuncture on GB34 and the scalp significantly increased glucose metabolism bilaterally in the frontal and occipital lobes and improved motor dysfunction in patients with PD [179, 180].

In light of signal transduction, EA at 2 Hz on GV16 and LR3 inactivate the ERK 1/2 signaling pathway and p38/MAPK signaling pathway, causing an increase in tyrosine hydroxylase–positive neurons and a decrease in COX-2, TNF-α, and IL-1β levels. The regulation of cytokines reduces the neuroinflammation of the SN and alleviates PD symptoms [158, 159]. Acupuncture also activates the PI3K/Akt pathway, which elevates the Bcl-2 level and reduces dopamine- and cAMP-regulated phosphoprotein of 32 kDa and Fos B. Through the activation of the PI3K/Akt pathway, acupuncture increases the dopamine turnover rate and availability in the synapse of the SN and striatum and regulates the tyrosine hydroxylase–positive cell cycle, thus improving motor function [160162]. Lu et al. demonstrated that EA on KI3 inactivates pPKA/pPKC/CaMKIIα signaling pathways and reduces neuronal excitotoxicity in the hippocampus [163].

Rapamycin, an inhibitor of mTOR, is a potent inducer of autophagy and has an effect on PD [181]. However, rapamycin-based treatments for PD show adverse effects, including dyslipidemia, proliferative dysregulation, and renal dysfunction [182]. Acupuncture on GB34 affected the downstream autophagy–lysosome pathway through the m-TOR-independent pathway; this effect was comparable to that observed in the rapamycin treatment group [164]. Acupuncture induced autophagic clearance of α-syn, caused recovery of DA neurons in the SN, and improved motor function of an animal model without any notable adverse effect [164].

Oxidative stress and inflammation both contribute to the neural toxicity and development of PD [183]. Many studies have indicated the use of high-frequency EA for treating PD motor symptoms in animal models [184, 185]. Kim et al. reported that high-frequency EA on GB34 and GB39 increased tyrosine hydroxylase–positive neurons and cytochrome c oxidase subunit Vb and reduced cytosolic malate dehydrogenase, munc18-1, and hydroxyacylglutathione hydrolase levels, thus exerting an antioxidative effect on the SN [165]. Lv et al. demonstrated that EA at 100 Hz on ST36 and SP6 exerted a neuroprotective effect on PD mice and reversed the increase in the levels of Iba-1 and proinflammatory cytokines, including TNF-α, IL-6, and IL-1β, induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), thus suppressing the neuroinflammatory process [166]. The nuclear factor erythroid 2 -related factor 2 (Nrf2)–antioxidant response element (ARE) pathway regulates oxidative stress and inflammatory responses. EA enhances the Nrf2–ARE pathway and regulates the expression of antioxidants, such as the ARE-driven reporter gene, nicotinamide adenine dinucleotide phosphate quinone oxidoreductase, and heme oxygenase-1 (HO-1), thus relieving PD symptoms [166]. Similarly, Deng et al. reported that EA at 100 Hz on ST36 and SP6 elevated HO-1 and glutamate–cysteine ligase modifier subunits and reduced astrogliosis and neuroinflammation through the Nrf2–ARE pathway [167].

PD symptoms were relieved through the modification of TLR/NF-κB and Nrf2/HO-1 pathways [186]. EA on GV16 and LR3 upregulated NFκB protein expression and downregulated 26S proteasome protein expression in rotenone-induced PD rats [187]. P53 plays a role in DNA repair or cell death depending on the nature and extent of stress and damage [188]. P53 dysfunction was reported in neurodegenerative diseases and cancers [189]. Park et al. demonstrated that acupuncture on GB34 activated the p53 signaling pathway, protected dopaminergic neurons in the SN and striatum, and treated PD symptoms [168].

At the gene level, Choi et al. demonstrated that EA regulated gene expression in the striatum and exerted a neuroprotective effect on MPTP parkinsonism mice [190, 191]. Yeo et al. performed a microarray analysis study of acupuncture on GB34 and LR3 in an MPTP mouse model of parkinsonism and reported that acupuncture reversed the downregulation of five annotated genes and upregulation of three annotated genes through MPTP intoxication [192].

In summary, acupuncture improved motor dysfunction and memory of PD. These effects were accompanied by the regulation of gene expression. Acupuncture modulates neuroinflammation by inactivating ERK 1/2 and p38/MAPK signaling pathway and reduces neuronal excitotoxicity through the pPKA/pPKC/CaMKIIα signaling pathway. Acupuncture also regulates apoptosis by balancing the Bcl-2 and m-TOR-independent pathway. The most chosen acupoints include GB34, LR3, and GV16. Moreover, high-frequency EA (100 Hz) on ST36 and SP6 reduces neuroinflammation through the Nrf2–ARE pathway. The mechanisms and main results of identified articles are summarized in Table 7.

10. Conclusion

Acupuncture treats nervous system diseases through many signal transduction pathways. Besides increasing the neurotrophic factors level, acupuncture influences pathways including p38 MAPKs, Raf/MAPK/ERK1/2, TLR4/ERK, PI3K/AKT, AC/cAMP/PKA, ASK1–JNK/p38, and downstream CREB, JNK, m-TOR, NF-κB, and Bcl-2/Bax balance. We summarized the common signal transduction pathways through which acupuncture treats nervous system diseases (Figure 2). Through the aforementioned pathways, acupuncture affects synaptic plasticity, elevates neurotrophic factors, and results in neuroprotection, cell proliferation, antiapoptosis, antioxidant activity, anti-inflammation, and maintenance of the BBB.

Data Availability

The data in this study are available to other researchers upon request.

Conflicts of Interest

We declare that there are no conflicts of interest associated with this manuscript, and no significant financial support was received that would influence our findings.

Authors’ Contributions

Hsiang-Chun Lai collected data and wrote the manuscript, Qwang-Yuen Chang participated in discussions and provided suggestions, and Ching-Liang Hsieh provided an informed opinion and revised the manuscript.

Acknowledgments

This work was financially supported by the “Chinese Medicine Research Center, China Medical University” from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan (CMRC-CENTER-0). This study also was supported by grant DMR-108-176 from China Medical University Hospital.

References

  1. W. Zhou and P. Benharash, “Effects and mechanisms of acupuncture based on the principle of meridians,” Journal of Acupuncture and Meridian Studies, vol. 7, no. 4, pp. 190–193, 2014. View at: Publisher Site | Google Scholar
  2. X. R. He, Q. Wang, and P. P. Li, “Acupuncture and moxibustion for cancer-related fatigue: a systematic review and meta-analysis,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 5, pp. 3067–3074, 2013. View at: Publisher Site | Google Scholar
  3. J. Cox, S. Varatharajan, P. Côté, and Optima Collaboration, “Effectiveness of acupuncture therapies to manage musculoskeletal disorders of the extremities: a systematic review,” Journal of Orthopaedic and Sports Physical Therapy, vol. 46, no. 6, pp. 409–429, 2016. View at: Publisher Site | Google Scholar
  4. J. C. Forde, E. Jaffe, B. V. Stone, A. E. Te, G. Espinosa, and B. Chughtai, “The role of acupuncture in managing overactive bladder; a review of the literature,” International Urogynecology Journal, vol. 27, no. 11, pp. 1645–1651, 2016. View at: Publisher Site | Google Scholar
  5. Q. Yao, S. Li, X. Liu, Z. Qin, and Z. Liu, “The effectiveness and safety of acupuncture for patients with chronic urticaria: a systematic review,” BioMed Research International, vol. 2016, Article ID 5191729, 7 pages, 2016. View at: Publisher Site | Google Scholar
  6. A. Y. Fan, D. W. Miller, B. Bolash et al., “Acupuncture's role in solving the opioid epidemic: evidence, cost-effectiveness, and care availability for acupuncture as a primary, non-pharmacologic method for pain relief and management–white paper 2017,” Journal of Integrative Medicine, vol. 15, no. 6, pp. 411–425, 2017. View at: Publisher Site | Google Scholar
  7. J. Park, Y. Sohn, A. R. White, and H. Lee, “The safety of acupuncture during pregnancy: a systematic review,” Acupuncture in Medicine, vol. 32, no. 3, pp. 257–266, 2014. View at: Publisher Site | Google Scholar
  8. C. Yang, Z. Hao, L. Zhang, and Q. Guo, “Efficacy and safety of acupuncture in children: an overview of systematic reviews,” Pediatric Research, vol. 78, no. 2, pp. 112–119, 2015. View at: Publisher Site | Google Scholar
  9. K. Wang, H. Wu, G. Wang, M. Li, Z. Zhang, and G. Gu, “The effects of electroacupuncture on Th1/Th2 cytokine mRNA expression and mitogen-activated protein kinase signaling pathways in the splenic t cells of traumatized rats,” Anesthesia & Analgesia, vol. 109, no. 5, pp. 1666–1673, 2009. View at: Publisher Site | Google Scholar
  10. K. J. Cheng, “Neurobiological mechanisms of acupuncture for some common illnesses: a clinician's perspective,” Journal of Acupuncture and Meridian Studies, vol. 7, no. 3, pp. 105–114, 2014. View at: Publisher Site | Google Scholar
  11. R. L. Cai, G. M. Shen, H. Wang, and Y. Y. Guan, “Brain functional connectivity network studies of acupuncture: a systematic review on resting-state fMRI,” Journal of Integrative Medicine, vol. 16, no. 1, pp. 26–33, 2018. View at: Google Scholar
  12. X. Xue, Y. You, J. Tao et al., “Electro-acupuncture at points of Zusanli and Quchi exerts anti-apoptotic effect through the modulation of PI3K/Akt signaling pathway,” Neuroscience Letters, vol. 558, pp. 14–19, 2014. View at: Publisher Site | Google Scholar
  13. H. Wang, L. Wang, F. Liang et al., “Effects of electroacupuncture on electrocardiogram, myocardial pathological morphology and PI3K/Akt pathway in rats with chronic myocardial ischemia,” Zhongguo Zhen Jiu, vol. 36, no. 4, pp. 389–395, 2016. View at: Google Scholar
  14. H. Liao, M. Sun, J. Lin, S. Chang, and Y. Lee, “Electroacupuncture plus metformin lowers glucose levels and facilitates insulin sensitivity by activating mapk in steroid-induced insulin-resistant rats,” Acupuncture in Medicine, vol. 33, no. 5, pp. 388–394, 2018. View at: Publisher Site | Google Scholar
  15. H. Zhang, F. Qin, A. Liu et al., “Electro-acupuncture attenuates the mice premature ovarian failure via mediating PI3K/AKT/mTOR pathway,” Life Sciences, vol. 217, pp. 169–175, 2019. View at: Publisher Site | Google Scholar
  16. I. K. Hwang, J. Y. Chung, D. Y. Yoo et al., “Effects of electroacupuncture at Zusanli and Baihui on brain-derived neurotrophic factor and cyclic AMP response element-binding protein in the hippocampal dentate gyrus,” Journal of Veterinary Medical Science, vol. 72, no. 11, pp. 1431–1436, 2010. View at: Publisher Site | Google Scholar
  17. X. Y. Liu, H. F. Zhou, Y. L. Pan et al., “Electro-acupuncture stimulation protects dopaminergic neurons from inflammation-mediated damage in medial forebrain bundle-transected rats,” Experimental Neurology, vol. 189, no. 1, pp. 189–196, 2004. View at: Publisher Site | Google Scholar
  18. X. Ding, J. Yu, T. Yu, Y. Fu, and J. Han, “Acupuncture regulates the aging-related changes in gene profile expression of the hippocampus in senescence-accelerated mouse (SAMP10),” Neuroscience Letters, vol. 399, no. 1-2, pp. 11–16, 2006. View at: Publisher Site | Google Scholar
  19. Y. Zhang, R. Lan, J. Wang et al., “Acupuncture reduced apoptosis and up-regulated BDNF and GDNF expression in hippocampus following hypoxia-ischemia in neonatal rats,” Journal of Ethnopharmacology, vol. 172, pp. 124–132, 2015. View at: Publisher Site | Google Scholar
  20. W. G. Dong, W. Q. Guo, X. H. Zheng et al., “Electroacupuncture improves cognitive deficits associated with AMPK activation in SAMP8 mice,” Metabolic Brain Disease, vol. 30, no. 3, pp. 777–784, 2015. View at: Publisher Site | Google Scholar
  21. L. Lu, X. G. Zhang, L. L. Zhong et al., “Acupuncture for neurogenesis in experimental ischemic stroke: a systematic review and meta-analysis,” Scientific Reports, vol. 6, Article ID 19521, 2016. View at: Google Scholar
  22. L. M. Chavez, S. S. Huang, I. MacDonald, J. G. Lin, Y. C. Lee, and Y. H. Chen, “Mechanisms of acupuncture therapy in ischemic stroke rehabilitation: a literature review of basic studies,” International Journal of Molecular Sciences, vol. 18, no. 11, 2017. View at: Google Scholar
  23. C. C. Shih, C. C. Liao, M. F. Sun et al., “A Retrospective cohort study comparing stroke recurrence rate in ischemic stroke patients with and without acupuncture treatment,” Medicine, vol. 94, no. 39, Article ID e1572, 2015. View at: Publisher Site | Google Scholar
  24. T. Yang, S. Sun, T. Wang et al., “Piperlonguminine is neuroprotective in experimental rat stroke,” International Immunopharmacology, vol. 23, no. 2, pp. 447–451, 2014. View at: Publisher Site | Google Scholar
  25. T. Xu, N. Xu, Z. Yang, Y. Wan, Q. Wu, and K. Huang, “Neuroprotective effects of electroacupuncture on hypoxic-ischemic encephalopathy in newborn rats are associated with increased expression of GDNF-RET and protein kinase B,” Chinese Journal of Integrative Medicine, vol. 22, no. 6, pp. 457–466, 2016. View at: Publisher Site | Google Scholar
  26. H. K. Shin, S.-W. Lee, and B. T. Choi, “Modulation of neurogenesis via neurotrophic factors in acupuncture treatments for neurological diseases,” Biochemical Pharmacology, vol. 141, pp. 132–142, 2017. View at: Publisher Site | Google Scholar
  27. Y. R. Kim, H. N. Kim, S. M. Ahn, Y. H. Choi, H. K. Shin, and B. T. Choi, “Electroacupuncture promotes post-stroke functional recovery via enhancing endogenous neurogenesis in mouse focal cerebral ischemia,” PLoS ONE, vol. 9, no. 2, Article ID e90000, 2014. View at: Publisher Site | Google Scholar
  28. M. Kim, M.-W. Kim, Y. C. Chung et al., “Electroacupuncture enhances motor recovery performance with brain-Derived neurotrophic factor expression in rats with cerebral infarction,” Acupuncture in Medicine, vol. 30, no. 3, pp. 222–226, 2012. View at: Publisher Site | Google Scholar
  29. J. Huang, X. Ye, Y. You et al., “Electroacupuncture promotes neural cell proliferation in vivo through activation of the ERK1/2 signaling pathway,” International Journal of Molecular Medicine, vol. 33, no. 6, pp. 1547–1553, 2014. View at: Publisher Site | Google Scholar
  30. N. Sawe, G. Steinberg, and H. Zhao, “Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke,” Journal of Neuroscience Research, vol. 86, no. 8, pp. 1659–1669, 2008. View at: Publisher Site | Google Scholar
  31. T. W. Lai, S. Zhang, and Y. T. Wang, “Excitotoxicity and stroke: identifying novel targets for neuroprotection,” Progress in Neurobiology, vol. 115, pp. 157–188, 2014. View at: Publisher Site | Google Scholar
  32. J. Du, Q. Wang, B. Hu et al., “Involvement of ERK 1/2 activation in electroacupuncture pretreatment via cannabinoid CB1 receptor in rats,” Brain Research, vol. 1360, pp. 1–7, 2010. View at: Publisher Site | Google Scholar
  33. G. Xie, S. Yang, A. Chen et al., “Electroacupuncture at Quchi and Zusanli treats cerebral ischemia-reperfusion injury through activation of ERK signaling,” Experimental and Therapeutic Medicine, vol. 5, no. 6, pp. 1593–1597, 2013. View at: Publisher Site | Google Scholar
  34. C. Y. Cheng, J. G. Lin, S. Y. Su, N. Y. Tang, S. T. Kao, and C. L. Hsieh, “Electroacupuncture-like stimulation at Baihui and Dazhui acupoints exerts neuroprotective effects through activation of the brain-derived neurotrophic factor-mediated MEK1/2/ERK1/2/p90RSK/bad signaling pathway in mild transient focal cerebral ischemia in rats,” BMC Complementary and Alternative Medicine, vol. 14, p. 92, 2014. View at: Google Scholar
  35. C. Wu, J. Wang, C. Li et al., “Effect of electroacupuncture on cell apoptosis and erk signal pathway in the hippocampus of adult rats with cerebral ischemia-reperfusion,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 414965, 10 pages, 2015. View at: Publisher Site | Google Scholar
  36. C. Wu, C. Li, G. Zhou et al., “Effects of electroacupuncture on the cortical extracellular signal regulated kinase pathway in rats with cerebral ischaemia/reperfusion,” Acupuncture in Medicine, vol. 35, no. 6, pp. 430–436, 2018. View at: Publisher Site | Google Scholar
  37. G. L. Johnson and R. Lapadat, “Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases,” Science, vol. 298, no. 5600, pp. 1911-1912, 2002. View at: Publisher Site | Google Scholar
  38. S. Yang, Y. Yuan, S. Jiao, Q. Luo, and J. Yu, “Calcitonin gene-related peptide protects rats from cerebral ischemia/reperfusion injury via a mechanism of action in the MAPK pathway,” Biomedical Reports, vol. 4, no. 6, pp. 699–703, 2016. View at: Publisher Site | Google Scholar
  39. C.-Y. Cheng, N.-Y. Tang, S.-T. Kao, and C.-L. Hsieh, “Ferulic acid administered at various time points protects against cerebral infarction by activating p38 MAPK/p90RSK/CREB/Bcl-2 anti-apoptotic signaling in the subacute phase of cerebral ischemia-reperfusion injury in rats,” PLoS ONE, vol. 11, no. 5, Article ID e0155748, 2016. View at: Google Scholar
  40. C.-Y. Cheng, T.-Y. Ho, C.-Y. Hsiang et al., “Angelica sinensis exerts angiogenic and anti-apoptotic effects against cerebral ischemia-reperfusion injury by activating p38MAPK/HIF-1 α /VEGF-A signaling in rats,” American Journal of Chinese Medicine, vol. 45, no. 8, pp. 1683–1708, 2017. View at: Publisher Site | Google Scholar
  41. X. Lan, X. Zhang, G. Zhou, C. Wu, C. Li, and X. Xu, “Electroacupuncture reduces apoptotic index and inhibits p38 mitogen-activated protein kinase signaling pathway in the hippocampus of rats with cerebral ischemia/reperfusion injury,” Neural Regeneration Research, vol. 12, no. 3, pp. 409–416, 2017. View at: Publisher Site | Google Scholar
  42. Y. Lin, Q. Liu, C. Chen et al., “Effect of acupuncture combined with hypothermia on MAPK/ERK pathway and apoptosis related factors in rats with cerebral ischemia reperfusion injury,” Journal of Central South University. Medical Sciences, vol. 42, no. 4, pp. 380–388, 2017. View at: Google Scholar
  43. Y. Xing, S. Yang, M. Wang, F. Dong, Y. Feng, and F. Zhang, “Electroacupuncture alleviated neuronal apoptosis following ischemic stroke in rats via midkine and ERK/JNK/p38 signaling pathway,” Journal of Molecular Neuroscience, vol. 66, no. 1, pp. 26–36, 2018. View at: Publisher Site | Google Scholar
  44. J. Liu, Q. Wang, S. Yang et al., “Electroacupuncture inhibits apoptosis of peri-ischemic regions via modulating p38, extracellular signal-regulated kinase (ERK1/2), and c-Jun N terminal kinases (jnk) in cerebral ischemia-reperfusion-injured rats,” Medical Science Monitor, vol. 24, pp. 4395–4404, 2018. View at: Publisher Site | Google Scholar
  45. W. Liu, X. Wang, S. Yang et al., “Electroacupunctre improves motor impairment via inhibition of microglia-mediated neuroinflammation in the sensorimotor cortex after ischemic stroke,” Life Sciences, vol. 151, pp. 313–322, 2016. View at: Publisher Site | Google Scholar
  46. C.-Y. Cheng, J.-G. Lin, N.-Y. Tang, S.-T. Kao, and C.-L. Hsieh, “Electroacupuncture at different frequencies (5Hz and 25Hz) ameliorates cerebral ischemia-reperfusion injury in rats: possible involvement of p38 MAPK-mediated anti-apoptotic signaling pathways,” BMC Complementary and Alternative Medicine, vol. 15, no. 1, p. 241, 2015. View at: Publisher Site | Google Scholar
  47. Q.-Q. Li, G.-X. Shi, J.-W. Yang et al., “Hippocampal cAMP/PKA/CREB is required for neuroprotective effect of acupuncture,” Physiology & Behavior, vol. 139, pp. 482–490, 2015. View at: Publisher Site | Google Scholar
  48. R. Lin, Y. Lin, J. Tao et al., “Electroacupuncture ameliorates learning and memory in rats with cerebral ischemia-reperfusion injury by inhibiting oxidative stress and promoting p-CREB expression in the hippocampus,” Molecular Medicine Reports, vol. 12, no. 5, pp. 6807–6814, 2015. View at: Publisher Site | Google Scholar
  49. S. M. Ahn, Y. R. Kim, H. N. Kim, Y. Shin, H. K. Shin, and B. T. Choi, “Electroacupuncture ameliorates memory impairments by enhancing oligodendrocyte regeneration in a mouse model of prolonged cerebral hypoperfusion,” Scientific Reports, vol. 6, no. 1, Article ID 28646, 2016. View at: Publisher Site | Google Scholar
  50. Y. Zhang, R. Lin, J. Tao et al., “Electroacupuncture improves cognitive ability following cerebral ischemia reperfusion injury via CaM-CaMKIV-CREB signaling in the rat hippocampus,” Experimental and Therapeutic Medicine, vol. 12, no. 2, pp. 777–782, 2016. View at: Publisher Site | Google Scholar
  51. Y. C. Yun, D. Jang, S. B. Yoon et al., “Laser acupuncture exerts neuroprotective effects via regulation of Creb, Bdnf, Bcl-2, and Bax gene expressions in the hippocampus,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, Article ID 7181637, 11 pages, 2017. View at: Publisher Site | Google Scholar
  52. M. E. Pak, D. H. Jung, H. J. Lee et al., “Combined therapy involving electroacupuncture and treadmill exercise attenuates demyelination in the corpus callosum by stimulating oligodendrogenesis in a rat model of neonatal hypoxia-ischemia,” Experimental Neurology, vol. 300, pp. 222–231, 2018. View at: Publisher Site | Google Scholar
  53. T. Ishrat, I. Sayeed, F. Atif, F. Hua, and D. G. Stein, “Progesterone is neuroprotective against ischemic brain injury through its effects on the phosphoinositide 3-kinase/protein kinase B signaling pathway,” Neuroscience, vol. 210, pp. 442–450, 2012. View at: Publisher Site | Google Scholar
  54. J. Zhou, T. Du, B. Li, Y. Rong, A. Verkhratsky, and L. Peng, “Crosstalk between MAPK/ERK and PI3K/AKT signal pathways during brain ischemia/reperfusion,” ASN Neuro, vol. 7, no. 5, 2015. View at: Google Scholar
  55. S. J. Wang, N. Omori, F. Li et al., “Potentiation of Akt and suppression of caspase-9 activations by electroacupuncture after transient middle cerebral artery occlusion in rats,” Neuroscience Letters, vol. 331, no. 2, pp. 115–118, 2002. View at: Publisher Site | Google Scholar
  56. N. Sun, X. Zou, J. Shi, X. Liu, L. Li, and L. Zhao, “Electroacupuncture regulates NMDA receptor NR1 subunit expression via PI3-K pathway in a rat model of cerebral ischemia-reperfusion,” Brain Research, vol. 1064, no. 1-2, pp. 98–107, 2005. View at: Publisher Site | Google Scholar
  57. L. Zhao, Y. Wang, N. Sun, X. Liu, L. Li, and J. Shi, “Electroacupuncture regulates TRPM7 expression through the trkA/PI3K pathway after cerebral ischemia–reperfusion in rats,” Life Sciences, vol. 81, no. 15, pp. 1211–1222, 2007. View at: Publisher Site | Google Scholar
  58. S.-X. Chen, M.-C. Ding, and K.-Y. Dai, “Effect of electroacupuncture on nitric oxide synthase in rats with cerebral ischemia-reperfusion injury,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 31, no. 6, pp. 784–788, 2011. View at: Google Scholar
  59. A. Chen, Z. Lin, L. Lan et al., “Electroacupuncture at the Quchi and Zusanli acupoints exerts neuroprotective role in cerebral ischemia-reperfusion injured rats via activation of the PI3K/Akt pathway,” International Journal of Molecular Medicine, vol. 30, no. 4, pp. 791–796, 2012. View at: Publisher Site | Google Scholar
  60. T. Xu, W. Li, Y. Liang et al., “Neuroprotective effects of electro acupuncture on hypoxic-ischemic encephalopathy in newborn rats Ass,” Pakistan Journal of Pharmaceutical Sciences, vol. 27, no. 6, supplement, pp. 1991–2000, 2014. View at: Google Scholar
  61. Y. R. Kim, H. N. Kim, J. Y. Jang et al., “Effects of electroacupuncture on apoptotic pathways in a rat model of focal cerebral ischemia,” International Journal of Molecular Medicine, vol. 32, no. 6, pp. 1303–1310, 2013. View at: Publisher Site | Google Scholar
  62. W. Liu, G. Shang, S. Yang et al., “Electroacupuncture protects against ischemic stroke by reducing autophagosome formation and inhibiting autophagy through the mTORC1-ULK1 complex-Beclin1 pathway,” International Journal of Molecular Medicine, vol. 37, no. 2, pp. 309–318, 2016. View at: Publisher Site | Google Scholar
  63. C. C. Xie, Y. Luo, Y. S. Pang et al., “Effect of electroacupuncture on CD 34+ endothelial progenitor cell counts in bone marrow and peripheral blood in focal cerebral ischemia/reperfusion rats,” Zhen Ci Yan Jiu, vol. 39, no. 6, pp. 437–442, 2014. View at: Google Scholar
  64. H. Wei, X. Yao, L. Yang et al., “Glycogen synthase kinase-3β is involved in electroacupuncture pretreatment via the cannabinoid CB1 receptor in ischemic stroke,” Molecular Neurobiology, vol. 49, no. 1, pp. 326–336, 2014. View at: Publisher Site | Google Scholar
  65. R. Zou, Z. Wu, and S. Cui, “Electroacupuncture pretreatment attenuates blood-brain barrier disruption following cerebral ischemia/reperfusion,” Molecular Medicine Reports, vol. 12, no. 2, pp. 2027–2034, 2015. View at: Publisher Site | Google Scholar
  66. X. Feng, S. Yang, J. Liu et al., “Electroacupuncture ameliorates cognitive impairment through inhibition of NF-κB-mediated neuronal cell apoptosis in cerebral ischemia-reperfusion injured rats,” Molecular Medicine Reports, vol. 7, no. 5, pp. 1516–1522, 2013. View at: Publisher Site | Google Scholar
  67. L. Lan, J. Tao, A. Chen et al., “Electroacupuncture exerts anti-inflammatory effects in cerebral ischemia-reperfusion injured rats via suppression of the TLR4/NF-κB pathway,” International Journal of Molecular Medicine, vol. 31, no. 1, pp. 75–80, 2013. View at: Publisher Site | Google Scholar
  68. Z. Liu, L. Guan, Y. Wang, C.-L. Xie, X.-M. Lin, and G.-Q. Zheng, “History and mechanism for treatment of intracerebral hemorrhage with scalp acupuncture,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 895032, 9 pages, 2012. View at: Publisher Site | Google Scholar
  69. T. Li, J.-G. Zhao, G.-J. Tian, L. Zhang, and S.-J. Liu, “Clinical observation on effect of acupuncture on nervous functions of the patient after operation of. hypertensive cerebral hemorrhage,” Chinese Acupuncture & Moxibustion, vol. 26, no. 4, pp. 247–249, 2006. View at: Google Scholar
  70. H.-Q. Wang, C.-L. Bao, Z.-H. Jiao, and G.-R. Dong, “Efficacy and safety of penetration acupuncture on head for acute intracerebral hemorrhage: A randomized controlled study,” Medicine, vol. 95, no. 48, Article ID e5562, 2016. View at: Google Scholar
  71. H. Q. Li, J. H. Li, A. J. Liu, M. Y. Ye, and G. Q. Zheng, “GV20-based acupuncture for animal models of acute intracerebral haemorrhage: a preclinical systematic review and meta-analysis,” Acupuncture in Medicine, vol. 32, no. 6, pp. 495–502, 2014. View at: Publisher Site | Google Scholar
  72. G.-W. Zhang, W. Zou, and F. Liu, “Effects of the scalp acupuncture at baihui (DU20) through qubin (GB7) on the expressions of GDNF VEGF in the brain tissue of rats with acute intracerebral hemorrhage,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 32, no. 9, pp. 1264–1270, 2012. View at: Google Scholar
  73. H. Zhou, T. Tang, J. Zhong et al., “Electroacupuncture improves recovery after hemorrhagic brain injury by inducing the expression of angiopoietin-1 and -2 in rats,” BMC Complementary and Alternative Medicine, vol. 14, no. 1, p. 127, 2014. View at: Publisher Site | Google Scholar
  74. H. Liu, X. Sun, W. Zou et al., “Scalp acupuncture attenuates neurological deficits in a rat model of hemorrhagic stroke,” Complementary Therapies in Medicine, vol. 32, pp. 85–90, 2017. View at: Publisher Site | Google Scholar
  75. H. Q. Li, Y. Li, Z. X. Chen et al., “Electroacupuncture exerts neuroprotection through caveolin-1 mediated molecular pathway in intracerebral hemorrhage of rats,” Neural Plasticity, vol. 2016, Article ID 7308261, 8 pages, 2016. View at: Publisher Site | Google Scholar
  76. Y. Zhu, L. Deng, H. Tang et al., “Electroacupuncture improves neurobehavioral function and brain injury in rat model of intracerebral hemorrhage,” Brain Research Bulletin, vol. 131, pp. 123–132, 2017. View at: Publisher Site | Google Scholar
  77. Z. Li, X. Zheng, P. Li, E. S. Itoua, D. Moukassa, and F. Ndinga Andely, “Effects of acupuncture on mrna levels of apoptotic factors in perihematomal brain tissue during the acute phase of cerebral hemorrhage,” Medical Science Monitor, vol. 23, pp. 1522–1532, 2017. View at: Publisher Site | Google Scholar
  78. J. R. Gavvala and S. U. Schuele, “New-onset seizure in adults and adolescents: A review,” Journal of the American Medical Association, vol. 316, no. 24, pp. 2657–2668, 2016. View at: Publisher Site | Google Scholar
  79. E. M. Goldberg and D. A. Coulter, “Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction,” Nature Reviews Neuroscience, vol. 14, no. 5, pp. 337–349, 2013. View at: Publisher Site | Google Scholar
  80. P. Rong, A. Liu, J. Zhang et al., “An alternative therapy for drug-resistant epilepsy: transcutaneous auricular vagus nerve stimulation,” Chinese Medical Journal, vol. 127, no. 2, pp. 300–304, 2014. View at: Google Scholar
  81. D. K. Cheuk and V. Wong, “Acupuncture for epilepsy,” Cochrane Database of Systematic Reviews, vol. 5, Article ID CD005062, 2014. View at: Google Scholar
  82. S. Li, Z. Liu, W. Zhao, B. Jin, N. Li, and G. Luo, “Scalp acupuncture for epileptiform discharges of children with cerebral palsy,” Zhongguo Zhen Jiu, vol. 37, no. 3, pp. 265–268, 2017. View at: Google Scholar
  83. G. Sperk, A. Wieselthaler-Holzl, S. Pirker et al., “Glutamate decarboxylase 67 is expressed in hippocampal mossy fibers of temporal lobe epilepsy patients,” Hippocampus, vol. 22, no. 3, pp. 590–603, 2012. View at: Google Scholar
  84. M. Gulcebi, O. Akman, N. Carcak, T. Karamahmutoglu, and F. Onat, “Evaluation of GAD67 immunoreactivity in the region of substantia nigra pars reticulata in resistance to development of convulsive seizure in genetic absence epilepsy rats,” Northern Clinics of İstanbul, vol. 3, no. 3, pp. 161–167, 2017. View at: Google Scholar
  85. J. Guo, J. Liu, W. Fu et al., “The effect of electroacupuncture on spontaneous recurrent seizure and expression of GAD67 mRNA in dentate gyrus in a rat model of epilepsy,” Brain Research, vol. 1188, no. 1, pp. 165–172, 2008. View at: Publisher Site | Google Scholar
  86. J. Guo, J. Liu, W. Fu et al., “Effect of electroacupuncture stimulation of hindlimb on seizure incidence and supragranular mossy fiber sprouting in a rat model of epilepsy,” The Journal of Physiological Sciences, vol. 58, no. 5, pp. 309–315, 2008. View at: Publisher Site | Google Scholar
  87. A. Vezzani, “Epilepsy and inflammation in the brain: overview and pathophysiology,” Epilepsy Currents, vol. 14, no. 1, pp. 3–7, 2014. View at: Publisher Site | Google Scholar
  88. S. Kim, A. Doo, S. Kim et al., “Acupuncture suppresses kainic acid-induced neuronal death and inflammatory events in mouse hippocampus,” The Journal of Physiological Sciences, vol. 62, no. 5, pp. 377–383, 2012. View at: Publisher Site | Google Scholar
  89. E.-T. Liao, N.-Y. Tang, Y.-W. Lin, and C. Liang Hsieh, “Long-term electrical stimulation at ear and electro-acupuncture at ST36-ST37 attenuated COX-2 in the CA1 of hippocampus in kainic acid-induced epileptic seizure rats,” Scientific Reports, vol. 7, no. 1, p. 472, 2017. View at: Publisher Site | Google Scholar
  90. B. E. Wang and J. S. Cheng, “C-fos expression in rat brain during seizure and electroacupuncture,” Zhongguo Yao Li Xue Bao, vol. 15, no. 1, pp. 73–75, 1994. View at: Google Scholar
  91. B. Wang, R. Yang, and J. Cheng, “Effect of electroacupuncture on the level of preproenkephalin mrna in rat during penicillin-induced epilepsy,” Acupuncture & Electro-Therapeutics Research, vol. 19, no. 2, pp. 129–140, 1994. View at: Publisher Site | Google Scholar
  92. R. Yang, Z. N. Huang, and J. S. Cheng, “Anticonvulsion effect of acupuncture might be related to the decrease of neuronal and inducible nitric oxide synthases,” Acupuncture & Electro-Therapeutics Research, vol. 24, no. 3-4, pp. 161–167, 1999. View at: Publisher Site | Google Scholar
  93. Y.-W. Lin and C.-L. Hsieh, “Auricular electroacupuncture reduced inflammation-related epilepsy accompanied by altered TRPA1, pPKCα, pPKCε, and pERk1/2 signaling pathways in kainic acid-treated rats,” Mediators of Inflammation, vol. 2014, Article ID 493480, 9 pages, 2014. View at: Publisher Site | Google Scholar
  94. E.-T. Liao, Y.-W. Lin, C.-P. Huang, N.-Y. Tang, and C.-L. Hsieh, “Electric stimulation of ear reduces the effect of toll-like receptor 4 signaling pathway on kainic acid-induced epileptic seizures in rats,” BioMed Research International, vol. 2018, Article ID 5407256, 11 pages, 2018. View at: Publisher Site | Google Scholar
  95. F. Yang, W.-P. Ang, D.-K. Shen, X.-G. Liu, Y.-Q. Yang, and Y. Ma, “PI 3 K/Akt signaling pathway contributed to the protective effect of acupuncture intervention on epileptic seizure-induced injury of hippocampal pyramidal cells in epilepsy rats,” Zhen Ci Yan Jiu, vol. 38, no. 1, pp. 20–25, 2013. View at: Google Scholar
  96. F. Yang, Y. Ma, W.-P. Ang et al., “Effects of acupuncture intervention on expression of glucose-regulated protein 78 and C/EBP homologous protein in hippocampal CA 1 region in rats with hyperspasmia,” Zhen Ci Yan Jiu, vol. 39, no. 4, pp. 267–271, 2014. View at: Google Scholar
  97. H. Zhang, F. Yang, X. Wu et al., “Protective effect of acupuncture serum derived from acute convulsion rats on cultured hip-pocampal neurons with seizure-like discharges by regulating expression of endoplasmic reticulum stress-inducible molecular chaperones,” Acupuncture Research, vol. 42, no. 2, pp. 95–101, 2017. View at: Google Scholar
  98. D. A. Mrazek, J. C. Hornberger, C. A. Altar, and I. Degtiar, “A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996–2013,” Psychiatric Services, vol. 65, no. 8, pp. 977–987, 2014. View at: Publisher Site | Google Scholar
  99. N. E. Haddad and O. Palesh, “Acupuncture in the treatment of cancer-related psychological symptoms,” Integrative Cancer Therapies, vol. 13, no. 5, pp. 371–385, 2014. View at: Publisher Site | Google Scholar
  100. A. Bhattacharya, N. C. Derecki, T. W. Lovenberg, and W. C. Drevets, “Role of neuro-immunological factors in the pathophysiology of mood disorders,” Psychopharmacology, vol. 233, no. 9, pp. 1623–1636, 2016. View at: Publisher Site | Google Scholar
  101. W. Liu, T. Ge, Y. Leng et al., “The role of neural plasticity in depression: from hippocampus to prefrontal cortex,” Neural Plasticity, vol. 2017, Article ID 6871089, 11 pages, 2017. View at: Publisher Site | Google Scholar
  102. E. Kulikova and A. Kulikov, “Striatal-enriched tyrosine protein phosphatase (STEP) in the mechanisms of depressive disorders,” Current Protein & Peptide Science, vol. 18, no. 11, pp. 1152–1162, 2017. View at: Publisher Site | Google Scholar
  103. L. Hu, J. Liang, S. Y. Jin, Y. J. Han, J. Lu, and Y. Tu, “Progress of researches on mechanisms of acupuncture underlying improvement of depression in the past five years,” Zhen Ci Yan Jiu, vol. 38, no. 3, pp. 253–258, 2013. View at: Google Scholar
  104. J. Liang, J. Lu, S. F. Cui, J. R. Wang, and Y. Tu, “Effect of acupuncture on expression of brain-derived neurotrophic factor gene and protein in frontal cortex and hippocampus of depression rats,” Zhen Ci Yan Jiu, vol. 37, no. 1, pp. 20–24, 2012. View at: Google Scholar
  105. Q. Ji, Z.-G. Li, Y.-S. Tang, Y.-P. Mo, H.-J. Yao, and C.-K. Saiyin, “Effect of electroacupuncture intervention on behavioral changes and hippocampal excitatory amino acid transporter mRNA expression in depression rats,” Zhen Ci Yan Jiu, vol. 38, no. 3, pp. 202–207, 219, 2013. View at: Google Scholar
  106. L. Fan, Z. Chen, W. Fu et al., “Soluble N-ethylmaleimide-sensitive factor attachment receptor (SNARE) protein involved in the remission of depression by acupuncture in rats,” Journal of Acupuncture and Meridian Studies, vol. 9, no. 5, pp. 242–249, 2016. View at: Google Scholar
  107. Y. J. Han, W. X. Li, B. H. Jia, Y. J. Shi, and Y. Tu, “Effect of electroacupuncture on hippocampal NO-cGMP signaling pathway in depression rats,” Zhen Ci Yan Jiu, vol. 34, no. 4, pp. 236–241, 2009. View at: Google Scholar
  108. R. H. Shao, S. Y. Jin, J. Lu, L. Hu, and Y. Tu, “Effect of Acupuncture intervention on expression of NF-kappaB signal pathway in the hippocampus of chronic stress-induced depression rats,” Zhen Ci Yan Jiu, vol. 40, no. 5, pp. 368–372, 2015. View at: Google Scholar
  109. J. Lu, J. Liang, J.-R. Wang, L. Hu, Y. Tu, and J.-Y. Guo, “Acupuncture activates ERK-CREB pathway in rats exposed to chronic unpredictable mild stress,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 469765, 7 pages, 2013. View at: Publisher Site | Google Scholar
  110. L. Yang, N. Yue, X. Zhu et al., “Electroacupuncture upregulates ERK signaling pathways and promotes adult hippocampal neural progenitors proliferation in a rat model of depression,” BMC Complementary and Alternative Medicine, vol. 13, p. 288, 2013. View at: Publisher Site | Google Scholar
  111. J. Xu, Y. She, N. Su, R. Zhang, L. Lao, and S. Xu, “Effects of electroacupuncture on chronic unpredictable mild stress rats depression-like behavior and expression of p-ERK/ERK and p-P38/P38,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 650729, 8 pages, 2015. View at: Publisher Site | Google Scholar
  112. X. Zhang, Y. Song, T. Bao et al., “Antidepressant-like effects of acupuncture involved the ERK signaling pathway in rats,” BMC Complementary and Alternative Medicine, vol. 16, no. 1, p. 380, 2016. View at: Publisher Site | Google Scholar
  113. W. Li, Y. Zhu, S. M. Saud et al., “Electroacupuncture relieves depression-like symptoms in rats exposed to chronic unpredictable mild stress by activating ERK signaling pathway,” Neuroscience Letters, vol. 642, pp. 43–50, 2017. View at: Publisher Site | Google Scholar
  114. X. Yang, Z. Guo, J. Lu et al., “The Role of MAPK and dopaminergic synapse signaling pathways in antidepressant effect of electroacupuncture pretreatment in chronic restraint stress rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, Article ID 2357653, 9 pages, 2017. View at: Publisher Site | Google Scholar
  115. W. Dai, W. D. Li, and J. Lu, “Effect of electroacupuncture on hippocampal apoptosis and JNK signal pathway in chronic stress depression rats,” Zhen Ci Yan Jiu, vol. 35, no. 5, pp. 330–334, 2010. View at: Google Scholar
  116. Y. Guo, K. Xu, W. Y. Bao et al., “Effect of acupuncture intervention on c-jun N-terminal kinase signaling in the hippocampus in rats with forced swimming stress,” Zhen Ci Yan Jiu, vol. 41, no. 1, pp. 18–23, 2016. View at: Google Scholar
  117. F. Lu, H. M. Zhu, J. J. Xie, H. H. Zhou, Y. L. Chen, and J. Y. Hu, “Effects of electroacupuncture on behavior, plasma COR and expressions of PKA and PKC in hippocampus of the depression model rat,” Zhongguo Zhen Jiu, vol. 28, no. 3, pp. 214–218, 2008. View at: Google Scholar
  118. J.-H. Liu, Z.-F. Wu, J. Sun, L. Jiang, S. Jiang, and W.-B. Fu, “Role of AC-cAMP-PKA cascade in antidepressant action of electroacupuncture treatment in rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 932414, 7 pages, 2012. View at: Publisher Site | Google Scholar
  119. D.-M. Duan, Y. Tu, P. Liu, and S. Jiao, “Antidepressant effect of electroacupuncture regulates signal targeting in the brain and increases brain-derived neurotrophic factor levels,” Neural Regeneration Research, vol. 11, no. 10, pp. 1595–1602, 2016. View at: Publisher Site | Google Scholar
  120. H. Jiang, X. Zhang, Y. Wang et al., “Mechanisms underlying the antidepressant response of acupuncture via PKA/CREB signaling pathway,” Neural Plasticity, vol. 2017, Article ID 4135164, 11 pages, 2017. View at: Publisher Site | Google Scholar
  121. J. Y. Oh, Y. K. Kim, S. N. Kim et al., “Acupuncture modulates stress response by the mTOR signaling pathway in a rat post-traumatic stress disorder model,” Scientific Reports, vol. 8, no. 1, p. 11864, 2018. View at: Publisher Site | Google Scholar
  122. D. M. Duan, X. Dong, Y. Tu, and P. Liu, “A microarray study of chronic unpredictable mild stress rat blood serum with electro-acupuncture intervention,” Neuroscience Letters, vol. 627, pp. 160–167, 2016. View at: Publisher Site | Google Scholar
  123. Y. Wang, H. Jiang, H. Meng et al., “Genome-wide transcriptome analysis of hippocampus in rats indicated that TLR/NLR signaling pathway was involved in the pathogenisis of depressive disorder induced by chronic restraint stress,” Brain Research Bulletin, vol. 134, pp. 195–204, 2017. View at: Publisher Site | Google Scholar
  124. Y. Wang, H. Jiang, H. Meng et al., “Antidepressant mechanism research of acupuncture: insights from a genome-wide transcriptome analysis of frontal cortex in rats with chronic restraint stress,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, Article ID 1676808, 13 pages, 2017. View at: Publisher Site | Google Scholar
  125. A. Burns and S. Iliffe, “Alzheimer's disease,” BMJ, vol. 338, p. b158, 2009. View at: Google Scholar
  126. C. Ballard, S. Gauthier, A. Corbett, C. Brayne, D. Aarsland, and E. Jones, “Alzheimer's disease,” The Lancet, vol. 377, no. 9770, pp. 1019–1031, 2011. View at: Publisher Site | Google Scholar
  127. Y. Jia, X. Zhang, J. Yu et al., “Acupuncture for patients with mild to moderate Alzheimer's disease: a randomized controlled trial,” BMC Complementary and Alternative Medicine, vol. 17, no. 1, p. 556, 2017. View at: Google Scholar
  128. S. Zhou, L. Dong, Y. He, and H. Xiao, “Acupuncture plus herbal medicine for alzheimer's disease: a systematic review and meta-analysis,” American Journal of Chinese Medicine, vol. 45, no. 7, pp. 1327–1344, 2017. View at: Publisher Site | Google Scholar
  129. H. Cheng, J. Yu, Z. Jiang et al., “Acupuncture improves cognitive deficits and regulates the brain cell proliferation of SAMP8 mice,” Neuroscience Letters, vol. 432, no. 2, pp. 111–116, 2008. View at: Publisher Site | Google Scholar
  130. X. Li, F. Guo, Q. Zhang et al., “Electroacupuncture decreases cognitive impairment and promotes neurogenesis in the APP/PS1 transgenic mice,” BMC Complementary and Alternative Medicine, vol. 14, p. 37, 2014. View at: Publisher Site | Google Scholar
  131. L. Y. Xiao, X. R. Wang, Y. Yang et al., “Applications of acupuncture therapy in modulating plasticity of central nervous system,” Neuromodulation, vol. 21, no. 8, pp. 762–776, 2018. View at: Google Scholar
  132. L. Zhao, C. Zhou, L. Li et al., “Acupuncture improves cerebral microenvironment in mice with alzheimer's disease treated with hippocampal neural stem cells,” Molecular Neurobiology, vol. 54, no. 7, pp. 5120–5130, 2017. View at: Google Scholar
  133. O. V. Vitolo, A. Sant'Angelo, V. Costanzo, F. Battaglia, O. Arancio, and M. Shelanski, “Amyloid beta-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 99, no. 20, pp. 13217–13221, 2002. View at: Publisher Site | Google Scholar
  134. L. Tong, R. Balazs, P. L. Thornton, and C. W. Cotman, “β-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons,” The Journal of Neuroscience, vol. 24, no. 30, pp. 6799–6809, 2004. View at: Publisher Site | Google Scholar
  135. B. Lee, B. Sur, J. Shim, D.-H. Hahm, and H. Lee, “Acupuncture stimulation improves scopolamine-induced cognitive impairment via activation of cholinergic system and regulation of BDNF and CREB expressions in rats,” BMC Complementary and Alternative Medicine, vol. 14, no. 1, p. 338, 2014. View at: Publisher Site | Google Scholar
  136. R. Lin, J. Chen, X. Li et al., “Electroacupuncture at the Baihui acupoint alleviates cognitive impairment and exerts neuroprotective effects by modulating the expression and processing of brain-derived neurotrophic factor in APP/PS1 transgenic mice,” Molecular Medicine Reports, vol. 13, no. 2, pp. 1611–1617, 2016. View at: Publisher Site | Google Scholar
  137. J.-Q. Fang, S.-X. Zhu, Y. Zhang, F. Wang, and Q.-Y. Zhu, “Effect of electroacupuncture on expression of phosphorylated P 38 MAPK and IL-1beta in frontal lobe and hippocampus in rats with Alzheimer's disease,” Zhen Ci Yan Jiu, vol. 38, no. 1, pp. 35–39, 2013. View at: Google Scholar
  138. M. Zhang, G. H. Xv, W. X. Wang, D. J. Meng, and Y. Ji, “Electroacupuncture improves cognitive deficits and activates PPAR-gamma in a rat model of Alzheimer's disease,” Acupuncture in Medicine, vol. 35, no. 1, pp. 44–51, 2017. View at: Google Scholar
  139. T. Liu, J. C. Yu, and J. X. Han, “Age-related changes of p130 expression in hippocampus and cerebral cortex and effects of acupuncture in SAMP 10,” Zhen Ci Yan Jiu, vol. 33, no. 4, pp. 223–244, 2008. View at: Google Scholar
  140. B. Luo, L. Zhao, X. Zhang et al., “Acupuncture upregulates G protein coupled activity in SAMP8 mice,” Acupuncture in Medicine, vol. 35, no. 4, pp. 289–296, 2018. View at: Publisher Site | Google Scholar
  141. F. Wang, H. Zhong, X. Li et al., “Electroacupuncture attenuates reference memory impairment associated with astrocytic NDRG2 suppression in APP/PS1 transgenic mice,” Molecular Neurobiology, vol. 50, no. 2, pp. 305–313, 2014. View at: Publisher Site | Google Scholar
  142. D. Lin, Q. Wu, X. Lin et al., “Brain-derived neurotrophic factor signaling pathway: modulation by acupuncture in telomerase knockout mice,” Alternative Therapies In Health And Medicine, vol. 21, no. 6, pp. 36–46, 2015. View at: Google Scholar
  143. Z.-B. Liu, W.-M. Niu, X.-B. Yang, X.-M. Niu, and W. Yuan, “Effect of 'Xiusanzhen' on expression of hippocampal Bcl-2 and Bax proteins in Alzheimer disease rats,” Zhen Ci Yan Jiu, vol. 36, no. 1, pp. 7–11, 2011. View at: Google Scholar
  144. H. D. Guo, J. X. Tian, J. Zhu et al., “Electroacupuncture suppressed neuronal apoptosis and improved cognitive impairment in the ad model rats possibly via downregulation of notch signaling pathway,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 393569, 9 pages, 2015. View at: Publisher Site | Google Scholar
  145. X.-Y. Li, L. Xu, C.-L. Liu, L.-S. Huang, and X.-Y. Zhu, “Electroacupuncture intervention inhibits the decline of learning-memory ability and overex- pression of cleaved caspase-3 and bax in hippocampus induced by isoflurane in APPswe/PS 1,” Zhen Ci Yan Jiu, vol. 41, no. 1, pp. 24–30, 2016. View at: Google Scholar
  146. R. Wang, J. J. Li, S. Diao et al., “Metabolic stress modulates Alzheimer's β-secretase gene transcription via SIRT1-PPARγ-PGC-1 in neurons,” Cell Metabolism, vol. 17, no. 5, pp. 685–694, 2013. View at: Publisher Site | Google Scholar
  147. W. Dong, F. Wang, W. Guo et al., “Abeta25-35 suppresses mitochondrial biogenesis in primary hippocampal neurons,” Cellular and Molecular Neurobiology, vol. 36, no. 1, pp. 83–91, 2016. View at: Google Scholar
  148. W. Liu, P. Zhuo, L. Li et al., “Activation of brain glucose metabolism ameliorating cognitive impairment in APP/PS1 transgenic mice by electroacupuncture,” Free Radical Biology & Medicine, vol. 112, pp. 174–190, 2017. View at: Publisher Site | Google Scholar
  149. Y. Lu, Y. Huang, C. Tang et al., “Brain areas involved in the acupuncture treatment of AD model rats: A PET study,” BMC Complementary and Alternative Medicine, vol. 14, no. 1, p. 178, 2014. View at: Publisher Site | Google Scholar
  150. J. Jiang, K. Gao, Y. Zhou et al., “Electroacupuncture treatment improves learning-memory ability and brain glucose metabolism in a mouse model of alzheimer’s disease: using morris water maze and Micro-PET,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 142129, 7 pages, 2015. View at: Publisher Site | Google Scholar
  151. W. Dong, W. Guo, F. Wang et al., “Electroacupuncture upregulates SIRT1-dependent PGC-1α expression in SAMP8 Mice,” Medical Science Monitor, vol. 21, pp. 3356–3362, 2015. View at: Publisher Site | Google Scholar
  152. W.-G. Dong, F. Wang, Y. Chen et al., “Electroacupuncture reduces Aβ production and bace1 expression in SAMP8 mice,” Frontiers in Aging Neuroscience, vol. 7, p. 148, 2015. View at: Publisher Site | Google Scholar
  153. E. J. Yang, M. Cai, and J. Lee, “Neuroprotective effects of electroacupuncture on an animal model of bilateral common carotid artery occlusion,” Molecular Neurobiology, vol. 53, no. 10, pp. 7228–7236, 2016. View at: Publisher Site | Google Scholar
  154. W. Zhu, X. Wang, S. Du et al., “Anti-oxidative and anti-apoptotic effects of acupuncture: role of thioredoxin-1 in the hippocampus of vascular dementia rats,” Neuroscience, vol. 379, pp. 281–291, 2018. View at: Publisher Site | Google Scholar
  155. T. Wang, C. Z. Liu, J. C. Yu, W. Jiang, and J. X. Han, “Acupuncture protected cerebral multi-infarction rats from memory impairment by regulating the expression of apoptosis related genes Bcl-2 and Bax in hippocampus,” Physiology & Behavior, vol. 96, no. 1, pp. 155–161, 2009. View at: Publisher Site | Google Scholar
  156. W. J. Tian, L. N. Huang, R. H. Wang, J. M. An, and M. Zhang, “Effects of scalp-acupuncture on astrocyte apoptosis in hippocampal CA 1 region in rats with vascular dementia,” Zhen Ci Yan Jiu, vol. 40, no. 1, pp. 6–12, 2015. View at: Google Scholar
  157. Y. Zhu, Y. Zeng, X. Wang, and X. Ye, “Effect of electroacupuncture on the expression of mTOR and eIF4E in hippocampus of rats with vascular dementia,” Neurological Sciences, vol. 34, no. 7, pp. 1093–1097, 2013. View at: Publisher Site | Google Scholar
  158. S. J. Wang, J. Q. Fang, J. Ma et al., “Influence of electroacupuncture on p38-mitogen activated protein kinase in substantia nigra cells of rats with Parkinson disease model,” Zhongguo Zhen Jiu, vol. 33, no. 4, pp. 329–333, 2013. View at: Google Scholar
  159. S. J. Wang, J. Ma, Y. X. Gong et al., “Effect of electroacupuncture intervention on ERK 1/2 signaling and TNF-alpha and IL-1beta protein levels in the substantia Nigra in rats with Parkinson's Disease,” Zhen Ci Yan Jiu, vol. 39, no. 6, pp. 456–460, 2014. View at: Google Scholar
  160. S. N. Kim, S. T. Kim, A. R. Doo et al., “Phosphatidylinositol 3-kinase/Akt signaling pathway mediates acupuncture-induced dopaminergic neuron protection and motor function improvement in a mouse model of Parkinson's disease,” International Journal of Neuroscience, vol. 121, no. 10, pp. 562–569, 2011. View at: Publisher Site | Google Scholar
  161. S.-N. Kim, A.-R. Doo, J.-Y. Park et al., “Acupuncture enhances the synaptic dopamine availability to improve motor function in a mouse model of Parkinson's disease,” PLoS ONE, vol. 6, no. 11, Article ID e27566, 2011. View at: Publisher Site | Google Scholar
  162. J. G. Lin, C. J. Chen, H. B. Yang, Y. H. Chen, and S. Y. Hung, “Electroacupuncture promotes recovery of motor function and reduces dopaminergic neuron degeneration in rodent models of Parkinson’s disease,” International Journal of Molecular Sciences, vol. 18, no. 9, p. 1846, 2017. View at: Publisher Site | Google Scholar
  163. K.-W. Lu, J. Yang, C.-L. Hsieh, Y.-C. Hsu, and Y.-W. Lin, “Electroacupuncture restores spatial learning and downregulates phosphorylated N-methyl-Daspartate receptors in a mouse model of Parkinson's disease,” Acupuncture in Medicine, vol. 35, no. 2, pp. 133–141, 2017. View at: Publisher Site | Google Scholar
  164. T. Tian, Y. Sun, H. Wu et al., “Acupuncture promotes mTOR-independent autophagic clearance of aggregation-prone proteins in mouse brain,” Scientific Reports, vol. 6, Article ID 19714, 2016. View at: Publisher Site | Google Scholar
  165. S. Kim, W. Moon, Y. Chae, Y. J. Kim, H. Lee, and H. Park, “The effect of electroaucpuncture for 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced proteomic changes in the mouse striatum,” The Journal of Physiological Sciences, vol. 60, no. 1, pp. 27–34, 2010. View at: Publisher Site | Google Scholar
  166. E. Lv, J. Deng, Y. Yu et al., “Nrf2-ARE signals mediated the anti-oxidative action of electroacupuncture in an MPTP mouse model of Parkinson's disease,” Free Radical Research, vol. 49, no. 11, pp. 1296–1307, 2015. View at: Publisher Site | Google Scholar
  167. J. Deng, E. Lv, J. Yang et al., “Electroacupuncture remediates glial dysfunction and ameliorates neurodegeneration in the astrocytic α-synuclein mutant mouse model,” Journal of Neuroinflammation, vol. 12, no. 1, p. 103, 2015. View at: Publisher Site | Google Scholar
  168. J.-Y. Park, H. Choi, S. Baek et al., “P53 signalling mediates acupuncture-induced neuroprotection in Parkinson's disease,” Biochemical and Biophysical Research Communications, vol. 460, no. 3, pp. 772–779, 2015. View at: Publisher Site | Google Scholar
  169. J. T. O'Brien and A. Thomas, “Vascular dementia,” The Lancet, vol. 386, no. 10004, pp. 1698–1706, 2015. View at: Publisher Site | Google Scholar
  170. S. T. Pendlebury and P. M. Rothwell, “Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis,” The Lancet Neurology, vol. 8, no. 11, pp. 1006–1018, 2009. View at: Publisher Site | Google Scholar
  171. J. Yu, X. Zhang, C. Liu, Y. Meng, and J. Han, “Effect of acupuncture treatment on vascular dementia,” Neurological Research, vol. 28, no. 1, pp. 97–103, 2006. View at: Publisher Site | Google Scholar
  172. G. X. Shi, Q. Q. Li, B. F. Yang et al., “Acupuncture for vascular dementia: a pragmatic randomized clinical trial,” The Scientific World Journal, vol. 2015, Article ID 161439, 8 pages, 2015. View at: Publisher Site | Google Scholar
  173. H. Yang, O. Shi, Y. Jin et al., “Functional protection of learning and memory abilities in rats with vascular dementia,” Restorative Neurology and Neuroscience, vol. 32, no. 5, pp. 689–700, 2014. View at: Google Scholar
  174. P. Rizek, N. Kumar, and M. S. Jog, “An update on the diagnosis and treatment of Parkinson disease,” Canadian Medical Association Journal, vol. 188, no. 16, pp. 1157–1165, 2016. View at: Publisher Site | Google Scholar
  175. B.-Y. Zeng and K. Zhao, “Effect of acupuncture on the motor and nonmotor symptoms in parkinson's disease-a review of clinical studies,” CNS Neuroscience & Therapeutics, vol. 22, no. 5, pp. 333–341, 2016. View at: Publisher Site | Google Scholar
  176. H. Noh, S. Kwon, S. Y. Cho et al., “Effectiveness and safety of acupuncture in the treatment of Parkinson's disease: A systematic review and meta-analysis of randomized controlled trials,” Complementary Therapies in Medicine, vol. 34, pp. 86–103, 2017. View at: Google Scholar
  177. H. Liu, L. Chen, Z. Zhang et al., “Effectiveness and safety of acupuncture combined with madopar for parkinson—s disease: a systematic review with meta-analysis,” Acupuncture in Medicine, vol. 35, no. 6, pp. 404–412, 2017. View at: Publisher Site | Google Scholar
  178. X.-B. Liang, X.-Y. Liu, F.-Q. Li et al., “Long-term high-frequency electro-acupuncture stimulation prevents neuronal degeneration and up-regulates BDNF mRNA in the substantia nigra and ventral tegmental area following medial forebrain bundle axotomy,” Brain Research. Molecular Brain Research, vol. 108, no. 1-2, pp. 51–59, 2002. View at: Publisher Site | Google Scholar
  179. B. D. Ghaffari and B. Kluger, “Mechanisms for alternative treatments in Parkinson's disease: acupuncture, tai chi, and other treatments,” Current Neurology and Neuroscience Reports, vol. 14, no. 6, p. 451, 2014. View at: Publisher Site | Google Scholar
  180. Z. Wang, H. Wan, J. Li, H. Zhang, and M. Tian, “Molecular imaging in traditional chinese medicine therapy for neurological diseases,” BioMed Research International, vol. 2013, Article ID 608430, 11 pages, 2013. View at: Publisher Site | Google Scholar
  181. J. Li, S. G. Kim, and J. Blenis, “Rapamycin: one drug, many effects,” Cell Metabolism, vol. 19, no. 3, pp. 373–379, 2014. View at: Publisher Site | Google Scholar
  182. B. Kahan, “Toxicity spectrum of inhibitors of mammalian target of rapamycin in organ transplantation: etiology, pathogenesis and treatment,” Expert Opinion on Drug Safety, vol. 10, no. 5, pp. 727–749, 2011. View at: Publisher Site | Google Scholar
  183. R. Niranjan, “The Role of inflammatory and oxidative stress mechanisms in the pathogenesis of parkinson's disease: focus on astrocytes,” Molecular Neurobiology, vol. 49, no. 1, pp. 28–38, 2014. View at: Publisher Site | Google Scholar
  184. J. Jia, Z. Sun, B. Li et al., “Electro-acupuncture stimulation improves motor disorders in Parkinsonian rats,” Behavioural Brain Research, vol. 205, no. 1, pp. 214–218, 2009. View at: Publisher Site | Google Scholar
  185. J. Jia, B. Li, Z.-L. Sun, F. Yu, X. Wang, and X.-M. Wang, “Electro-acupuncture stimulation acts on the basal ganglia output pathway to ameliorate motor impairment in Parkinsonian model rats,” Behavioral Neuroscience, vol. 124, no. 2, pp. 305–310, 2010. View at: Publisher Site | Google Scholar
  186. W. Xu, D. Zheng, Y. Liu, J. Li, L. Yang, and X. Shang, “Glaucocalyxin B alleviates lipopolysaccharide-induced Parkinson’s disease by inhibiting TLR/NF-κB and activating Nrf2/HO-1 pathway,” Cellular Physiology and Biochemistry, vol. 44, no. 6, pp. 2091–2104, 2018. View at: Publisher Site | Google Scholar
  187. Q. Tu, Y. Liang, J. Ma, S.-J. Wang, F. Shen, and Y.-C. Wang, “Effect of electroacupuncture on 26 S proteasome and nuclear factor kappa B in substantia nigra of rats with rotenone-induced Parkinson's disease,” Zhen Ci Yan Jiu, vol. 40, no. 4, pp. 259–264, 2015. View at: Google Scholar
  188. Z. Li, M. Ni, J. Li, Y. Zhang, Q. Ouyang, and C. Tang, “Decision making of the p53 network: Death by integration,” Journal of Theoretical Biology, vol. 271, no. 1, pp. 205–211, 2011. View at: Publisher Site | Google Scholar
  189. F. Checler and C. Alves da Costa, “p53 in neurodegenerative diseases and brain cancers,” Pharmacology & Therapeutics, vol. 142, no. 1, pp. 99–113, 2014. View at: Publisher Site | Google Scholar
  190. Y. Choi, S. Yeo, Y. Hong, S. Kim, and S. Lim, “Changes of gene expression profiles in the cervical spinal cord by acupuncture in an MPTP-intoxicated mouse model: Microarray analysis,” Gene, vol. 481, no. 1, pp. 7–16, 2011. View at: Publisher Site | Google Scholar
  191. Y.-G. Choi, S. Yeo, Y.-M. Hong, and S. Lim, “Neuroprotective changes of striatal degeneration-related gene expression by acupuncture in an MPTP mouse model of Parkinsonism: microarray analysis,” Cellular and Molecular Neurobiology, vol. 31, no. 3, pp. 377–391, 2011. View at: Publisher Site | Google Scholar
  192. S. Yeo, Y. Choi, Y. Hong, and S. Lim, “Neuroprotective changes of thalamic degeneration-related gene expression by acupuncture in an MPTP mouse model of parkinsonism: microarray analysis,” Gene, vol. 515, no. 2, pp. 329–338, 2013. View at: Publisher Site | Google Scholar

Copyright © 2019 Hsiang-Chun Lai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

1543 Views | 699 Downloads | 5 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.